A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
Non-susceptibility of an organism to the action of the cephalosporins.
Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.
Substances that reduce the growth or reproduction of BACTERIA.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
A cephalosporin antibiotic.
Cephalosporinase is an enzyme produced by certain bacteria that can hydrolyze and confer resistance to cephalosporin antibiotics.
Semisynthetic broad-spectrum cephalosporin.
A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.
A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
A broad-spectrum cephalosporin antibiotic with a very long half-life and high penetrability to meninges, eyes and inner ears.
A cephalosporin antibiotic.
A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.
Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.
One of the CEPHALOSPORINS that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.
A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.
Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.
A semi-synthetic cephalosporin antibiotic.
Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A beta-lactamase preferentially cleaving penicillins. (Dorland, 28th ed) EC 3.5.2.-.
A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
Infections with bacteria of the family ENTEROBACTERIACEAE.
A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.
Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate.
Nonsusceptibility of an organism to the action of penicillins.
Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.
Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.
Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It has been proposed especially against Pseudomonas infections.
A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.
A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.
Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative.
Infections with bacteria of the genus KLEBSIELLA.
Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.
Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in water, sewage, soil, meat, hospital environments, and on the skin and in the intestinal tract of man and animals as a commensal.
A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.
A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
Infections by bacteria, general or unspecified.
A cephalorsporin antibiotic.
Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
Clavulanic acid and its salts and esters. The acid is a suicide inhibitor of bacterial beta-lactamase enzymes from Streptomyces clavuligerus. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase.
Any infection which a patient contracts in a health-care institution.
Orally active semisynthetic cephalosporin antibiotic with broad-spectrum activity.
Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams.
A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed)
A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN.
Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879.
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA.
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.
A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.
Bacteria which retain the crystal violet stain when treated by Gram's method.
Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
Bacterial proteins that share the property of binding irreversibly to PENICILLINS and other ANTIBACTERIAL AGENTS derived from LACTAMS. The penicillin-binding proteins are primarily enzymes involved in CELL WALL biosynthesis including MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; PEPTIDE SYNTHASES; TRANSPEPTIDASES; and HEXOSYLTRANSFERASES.
Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotics. They lack the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized.
Infections with bacteria of the species ESCHERICHIA COLI.
The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.
A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
The composition, conformation, and properties of atoms and molecules, and their reaction and interaction processes.
A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.
Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors.
The process of cleaving a chemical compound by the addition of a molecule of water.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in soil, fecal matter, and sewage. It is an opportunistic pathogen and causes cystitis and pyelonephritis.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.
Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen.
Proteins found in any species of bacterium.
A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms.
Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.
Gram-negative rods isolated from human urine and feces.
Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
Deoxyribonucleic acid that makes up the genetic material of bacteria.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate EUKARYOTA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.
A serotype of SALMONELLA ENTERICA that causes mild PARATYPHOID FEVER in humans.
A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals.
A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.
The chemical and physical integrity of a pharmaceutical product.
A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.
Cephalosporin antibiotic, partly plasma-bound, that is effective against gram-negative and gram-positive organisms.
The rate dynamics in chemical or physical systems.
Gel electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length.
A genus of gram-positive, anaerobic bacteria whose organisms divide in three perpendicular planes and occur in packets of eight or more cells. It has been isolated from soil, grains, and clinical specimens.
Enzyme which catalyzes the peptide cross-linking of nascent CELL WALL; PEPTIDOGLYCAN.
Infections with bacteria of the genus SALMONELLA.
Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in fish and other aquatic animals and in a variety of mammals, including man. Its organisms probably do not belong to the normal intestinal flora of man and can cause diarrhea.
The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
One of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.
Acyltransferases that use AMINO ACYL TRNA as the amino acid donor in formation of a peptide bond. There are ribosomal and non-ribosomal peptidyltransferases.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.
An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.
A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.
Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.
A genus of gram-positive, coccoid bacteria consisting of organisms causing variable hemolysis that are normal flora of the intestinal tract. Previously thought to be a member of the genus STREPTOCOCCUS, it is now recognized as a separate genus.
A carboxypeptidase that is specific for proteins that contain two ALANINE residues on their C-terminal. Enzymes in this class play an important role in bacterial CELL WALL biosynthesis.
Institutions with an organized medical staff which provide medical care to patients.
Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
A large group of aerobic bacteria which show up as pink (negative) when treated by the gram-staining method. This is because the cell walls of gram-negative bacteria are low in peptidoglycan and thus have low affinity for violet stain and high affinity for the pink dye safranine.
A subgenus of Salmonella containing several medically important serotypes. The habitat for the majority of strains is warm-blooded animals.
The giving of drugs, chemicals, or other substances by mouth.
A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
Gram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections
A group of glycine amides of aminobenzoic acids.
A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics.
An enzyme catalyzing the hydrolysis of penicillin to penicin and a carboxylic acid anion. EC 3.5.1.11.
Gram-negative bacteria isolated from infections of the respiratory and intestinal tracts and from the buccal cavity, intestinal tract, and urogenital tract. They are probably part of the normal flora of man and animals.
Enzymes that catalyze the transfer of hexose groups. EC 2.4.1.-.
A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity.
A prolonged febrile illness commonly caused by several Paratyphi serotypes of SALMONELLA ENTERICA. It is similar to TYPHOID FEVER but less severe.
A genus of gram-negative, anaerobic, rod-shaped bacteria. Its organisms are normal inhabitants of the oral, respiratory, intestinal, and urogenital cavities of humans, animals, and insects. Some species may be pathogenic.
A common inhabitant of the colon flora in human infants and sometimes in adults. It produces a toxin that causes pseudomembranous enterocolitis (ENTEROCOLITIS, PSEUDOMEMBRANOUS) in patients receiving antibiotic therapy.
A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER.
Semisynthetic penicillin-type antibiotic.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that utilizes citrate as a sole carbon source. It is pathogenic for humans, causing enteric fevers, gastroenteritis, and bacteremia. Food poisoning is the most common clinical manifestation. Organisms within this genus are separated on the basis of antigenic characteristics, sugar fermentation patterns, and bacteriophage susceptibility.
Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.
The action of a drug in promoting or enhancing the effectiveness of another drug.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
Nonsusceptibility of a microbe to the action of ampicillin, a penicillin derivative that interferes with cell wall synthesis.
Simultaneous resistance to several structurally and functionally distinct drugs.
A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII.
Porins are protein molecules that were originally found in the outer membrane of GRAM-NEGATIVE BACTERIA and that form multi-meric channels for the passive DIFFUSION of WATER; IONS; or other small molecules. Porins are present in bacterial CELL WALLS, as well as in plant, fungal, mammalian and other vertebrate CELL MEMBRANES and MITOCHONDRIAL MEMBRANES.
Bacterial infections of the leptomeninges and subarachnoid space, frequently involving the cerebral cortex, cranial nerves, cerebral blood vessels, spinal cord, and nerve roots.
Infections with bacteria of the genus PSEUDOMONAS.
A species of bacterium of the family NOCARDIACEAE, producing pulmonary infections in man.
A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
Inbred ICR mice are a strain of albino laboratory mice that have been selectively bred for consistent genetic makeup and high reproductive performance, making them widely used in biomedical research for studies involving reproduction, toxicology, pharmacology, and carcinogenesis.
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Amidohydrolases are enzymes that catalyze the hydrolysis of amides and related compounds, playing a crucial role in various biological processes including the breakdown and synthesis of bioactive molecules.
Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.
An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.
Proteins isolated from the outer membrane of Gram-negative bacteria.
An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA.
Use of antibiotics before, during, or after a diagnostic, therapeutic, or surgical procedure to prevent infectious complications.
A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
An antibiotic derived from penicillin similar to CARBENICILLIN in action.
An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)
Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.
The method of measuring the dispersion of an optically active molecule to determine the relative magnitude of right- or left-handed components and sometimes structural features of the molecule.
A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.
Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
A mitosporic fungal genus with many reported ascomycetous teleomorphs. Cephalosporin antibiotics are derived from this genus.
A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.
An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
The functional hereditary units of BACTERIA.
Parliamentary democracy located between France on the northeast and Portugual on the west and bordered by the Atlantic Ocean and the Mediterranean Sea.
A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Analogs or derivatives of mandelic acid (alpha-hydroxybenzeneacetic acid).
Infections with bacteria of the genus ACINETOBACTER.
The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.
Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins.
A broad-spectrum antimicrobial carboxyfluoroquinoline.
Method of measuring the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy. It is used to monitor the therapy in BACTERIAL ENDOCARDITIS; OSTEOMYELITIS and other serious bacterial infections. As commonly performed, the test is a variation of the broth dilution test. This test needs to be distinguished from testing of the naturally occurring BLOOD BACTERICIDAL ACTIVITY.
A technique for identifying individuals of a species that is based on the uniqueness of their DNA sequence. Uniqueness is determined by identifying which combination of allelic variations occur in the individual at a statistically relevant number of different loci. In forensic studies, RESTRICTION FRAGMENT LENGTH POLYMORPHISM of multiple, highly polymorphic VNTR LOCI or MICROSATELLITE REPEAT loci are analyzed. The number of loci used for the profile depends on the ALLELE FREQUENCY in the population.
Inflammation of the tonsils, especially the PALATINE TONSILS but the ADENOIDS (pharyngeal tonsils) and lingual tonsils may also be involved. Tonsillitis usually is caused by bacterial infection. Tonsillitis may be acute, chronic, or recurrent.
Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research.
INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs.
Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING).
Directions written for the obtaining and use of DRUGS.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Ring compounds having atoms other than carbon in their nuclei. (Grant & Hackh's Chemical Dictionary, 5th ed)
An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections.
A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
Pathological developments in the CECUM.

Neural modulation of cephalexin intestinal absorption through the di- and tripeptide brush border transporter of rat jejunum in vivo. (1/3191)

Intestinal absorption of beta-lactamine antibiotics (e.g., cefixime and cephalexin) has been shown to proceed through the dipeptide carrier system. In a previous study, nifedipine (NFP), an L-type calcium channel blocker, enhanced the absorption of cefixime in vivo but not in vitro, and it was suggested that neural mechanisms might be involved in the effect of NFP. The aim of the present study was to assess the involvement of the nervous system on the intestinal absorption of cephalexin (CFX). To investigate this, we used a single-pass jejunal perfusion technique in rats. NFP and diltiazem enhanced approximately 2-fold the plasma levels of CFX in treated rats versus untreated controls. NFP also increased approximately 2-fold the CFX level in portal plasma and increased urinary excretion of CFX, thus indicating that CFX did effectively increase CFX intestinal absorption. Perfusing high concentrations of dipeptides in the jejunal lumen competitively reduced CFX absorption and inhibited the enhancement of CFX absorption produced by NFP. Hexamethonium and lidocaine inhibited the effect of NFP, whereas atropine, capsaicin, clonidine, and isoproterenol enhanced CFX absorption by the same order of magnitude as NFP. Thus, complex neural networks can modulate the function of the intestinal di- and tripeptide transporter. Sympathetic noradrenergic fibers, intestinal sensory neurons, and nicotinic synapses are involved in the increase of CFX absorption produced by NFP.  (+info)

In vitro activities of cephalosporins and quinolones against Escherichia coli strains isolated from diarrheic dairy calves. (2/3191)

The in vitro activities of several cephalosporins and quinolones against 195 strains of Escherichia coli isolated from diary calves affected by neonatal diarrhea were determined. One hundred thirty-seven of these strains produced one or more potential virulence factors (F5, F41, F17, cytotoxic necrotizing factor, verotoxin, and the eae gene), but the remaining 58 strains did not produce any of these factors. From 11 to 18% of the E. coli strains were resistant to cephalothin, nalidixic acid, enoxacin, and enrofloxacin. However, cefuroxime, cefotaxime, and cefquinome were highly effective against the E. coli isolates tested. Some significant differences (P < 0.05) in resistance to quinolones between the strains producing potential virulence factors and nonfimbriated, nontoxigenic, eae-negative strains were found. Thus, eae-positive, necrotoxigenic, and verotoxigenic (except for nalidixic acid) E. coli strains were significantly more sensitive to nalidixic acid, enoxacin, and enrofloxacin than nonfimbriated, nontoxigenic, eae-negative strains. Moreover, eae-positive strains were significantly more sensitive to enoxacin and enrofloxacin than F5-positive strains. Thus, the result of this study suggest that the bovine E. coli strains that produce some potential virulence factors are more sensitive to quinolones than those that do not express these factors.  (+info)

Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99. (3/3191)

Site-directed mutagenesis of Ser-289 of the class C beta-lactamase from Enterobacter cloacae P99 was performed to investigate the role of this residue in beta-lactam hydrolysis. This amino acid lies near the active site of the enzyme, where it can interact with the C-3 substituent of cephalosporins. Kinetic analysis of six mutant beta-lactamases with five cephalosporins showed that Ser-289 can be substituted by amino acids with nonpolar or polar uncharged side chains without altering the catalytic efficiency of the enzyme. These data suggest that Ser-289 is not essential in the binding or hydrolytic mechanism of AmpC beta-lactamase. However, replacement by Lys or Arg decreased by two- to threefold the kcat of four of the five beta-lactams tested, particularly cefoperazone, cephaloridine, and cephalothin. Three-dimensional models of the mutant beta-lactamases revealed that the length and positive charge of the side chain of Lys and Arg could create an electrostatic linkage to the C-4 carboxylic acid group of the dihydrothiazine ring of the acyl intermediate which could slow the deacylation step or hinder release of the product.  (+info)

Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta. (4/3191)

Treatment of septicemia caused by Escherichia coli with ceftazidime (CAZ) may be associated with the development of septic shock due to the release of bacterial lipopolysaccharide. We examined the suppressive effect of clindamycin (CLDM) on CAZ-induced release of endotoxin by cultured E. coli and the subsequent production of inflammatory cytokines (tumor necrosis factor alpha [TNF-alpha] and interleukin-1 beta [IL-1 beta]). E. coli ATCC 12014 was incubated in inactivated horse serum with or without CLDM for 1, 4, or 18 h, followed by the addition of CAZ and collection of the culture supernatant at 0, 1, and 2 h. The concentration of endotoxin in each sample was measured by a chromogenic Limulus test. Another portion of the culture supernatant was added to THP-1 cell culture and incubated for 4 h, and the concentrations of TNF-alpha and IL-1 beta in the supernatant were measured by an enzyme-linked immunosorbent assay. In the control group (no CLDM), CAZ administration resulted in significant increases in endotoxin, TNF-alpha, and IL-1 beta concentrations. Pretreatment of E. coli with CLDM for 4 or 18 h before the addition of CAZ significantly suppressed the concentrations of endotoxin, TNF-alpha, and IL-1 beta in a time-dependent manner. In addition, CAZ treatment transformed E. coli from rodshaped bacteria to filament-like structures, as determined by electron microscopy, while pretreatment with CLDM prevented these morphological changes. Our in vitro studies showed that CAZ-induced release of large quantities of endotoxin by E. coli could be suppressed by prior administration of CLDM.  (+info)

Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. (5/3191)

The purpose of this work was to evaluate the in vitro possibilities of ampicillin-ceftriaxone combinations for 10 Enterococcus faecalis strains with high-level resistance to aminoglycosides (HLRAg) and to assess the efficacy of ampicillin plus ceftriaxone, both administered with humanlike pharmacokinetics, for the treatment of experimental endocarditis due to HLRAg E. faecalis. A reduction of 1 to 4 dilutions in MICs of ampicillin was obtained when ampicillin was combined with a fixed subinhibitory ceftriaxone concentration of 4 micrograms/ml. This potentiating effect was also observed by the double disk method with all 10 strains. Time-kill studies performed with 1 and 2 micrograms of ampicillin alone per ml or in combination with 5, 10, 20, 40, and 60 micrograms of ceftriaxone per ml showed a > or = 2 log10 reduction in CFU per milliliter with respect to ampicillin alone and to the initial inoculum for all 10 E. faecalis strains studied. This effect was obtained for seven strains with the combination of 2 micrograms of ampicillin per ml plus 10 micrograms of ceftriaxone per ml and for six strains with 5 micrograms of ceftriaxone per ml. Animals with catheter-induced endocarditis were infected intravenously with 10(8) CFU of E. faecalis V48 or 10(5) CFU of E. faecalis V45 and were treated for 3 days with humanlike pharmacokinetics of 2 g of ampicillin every 4 h, alone or combined with 2 g of ceftriaxone every 12 h. The levels in serum and the pharmacokinetic parameters of the humanlike pharmacokinetics of ampicillin or ceftriaxone in rabbits were similar to those found in humans treated with 2 g of ampicillin or ceftriaxone intravenously. Results of the therapy for experimental endocarditis caused by E. faecalis V48 or V45 showed that the residual bacterial titers in aortic valve vegetations were significantly lower in the animals treated with the combinations of ampicillin plus ceftriaxone than in those treated with ampicillin alone (P < 0.001). The combination of ampicillin and ceftriaxone showed in vitro and in vivo synergism against HLRAg E. faecalis.  (+info)

Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococci. (6/3191)

In a context of worldwide emergence of resistance among Streptococcus pneumoniae strains, early detection of strains with decreased susceptibility to beta-lactam antibiotics is important for clinicians. If the 1-microgram oxacillin disk diffusion test is used as described by the National Committee for Clinical Laboratory Standards, no interpretation is available for strains showing zone sizes of /=2.0 microgram/ml) to penicillin. For ceftriaxone, among 98 strains with no zone of inhibition in response to oxacillin, 68 had intermediate resistance (MIC, 1.0 microgram/ml), and 22 were resistant (MIC, >/=2.0 microgram/ml). To optimize the use of the disk diffusion method, we propose that the absence of a zone of inhibition around the 1-microgram oxacillin disk be regarded as an indicator of nonsusceptibility to penicillin and ceftriaxone and recommend that such strains be reported as nonsusceptible to these antimicrobial agents, pending the results of a MIC quantitation method.  (+info)

Cefamandole: in vitro and clinical pharmacokinetics. (7/3191)

Cefamandole has a broader spectrum and greater potency than the other cephalosporins. It includes Haemophilus influenzae, most strains of Enterobacter, and many strains of indole-positive Proteus and Bacteroides, with a lower minimal inhibitory concentration for Escherichia coli, Klebsiella, etc. Concentrations of drug in the serum after the parenteral injection of cefamandole exceed manyfold the minimal inhibitory concentrations of over 82% of the bacteria studied. Approximately 65 to 85% is excreted in a biologically active form in the urine. This antibiotic offers advantages of antibacterial effectiveness and at the same time retains the safety of penicillin G and cephalothin in animals.  (+info)

Antibiotic penetrance of ascitic fluid in dogs. (8/3191)

Antibiotic concentrations in ascitic fluid after parenteral therapy may be important in the treatment of peritonitis. We have created ascites in dogs by partial ligation of the inferior vena cava. Ascitic fluid volume was measured at the time each antibiotic was administered. Nine antibiotics were studied in the same three dogs. Antibiotic concentration in ascitic fluid was found to vary inversely with ascites volume. Percentage of penetration (ratio of ascites peak to serum peak x100) ranged from 5.8 to 65% among the drugs studied. Only metronidazole showed a statistically significant higher percentage of penetration than other antimicrobials. Concentrations in ascitic fluid after single doses of cephalothin (15 mg/kg) and the aminoglycosides (2 mg/kg, gentamicin and tobramycin; 7.5 mg/kg, amikacin and kanamycin) did not exceed the minimum inhibitory concentration of many gram-negative rods and may justify the use of higher than usual initial parenteral doses, or possibly initial intraperitoneal administration in seriously ill patients.  (+info)

Cephalosporins are a class of antibiotics that are derived from the fungus Acremonium, originally isolated from seawater and cow dung. They have a similar chemical structure to penicillin and share a common four-membered beta-lactam ring in their molecular structure.

Cephalosporins work by inhibiting the synthesis of bacterial cell walls, which ultimately leads to bacterial death. They are broad-spectrum antibiotics, meaning they are effective against a wide range of bacteria, including both Gram-positive and Gram-negative organisms.

There are several generations of cephalosporins, each with different spectra of activity and pharmacokinetic properties. The first generation cephalosporins have a narrow spectrum of activity and are primarily used to treat infections caused by susceptible Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pneumoniae.

Second-generation cephalosporins have an expanded spectrum of activity that includes some Gram-negative organisms, such as Escherichia coli and Haemophilus influenzae. Third-generation cephalosporins have even broader spectra of activity and are effective against many resistant Gram-negative bacteria, such as Pseudomonas aeruginosa and Klebsiella pneumoniae.

Fourth-generation cephalosporins have activity against both Gram-positive and Gram-negative organisms, including some that are resistant to other antibiotics. They are often reserved for the treatment of serious infections caused by multidrug-resistant bacteria.

Cephalosporins are generally well tolerated, but like penicillin, they can cause allergic reactions in some individuals. Cross-reactivity between cephalosporins and penicillin is estimated to occur in 5-10% of patients with a history of penicillin allergy. Other potential adverse effects include gastrointestinal symptoms (such as nausea, vomiting, and diarrhea), neurotoxicity, and nephrotoxicity.

Cephalosporin resistance refers to the ability of bacteria to resist the antibacterial effects of cephalosporins, a group of widely used antibiotics. These drugs work by interfering with the bacterial cell wall synthesis, thereby inhibiting bacterial growth and reproduction. However, some bacteria have developed mechanisms that enable them to survive in the presence of cephalosporins.

There are several ways in which bacteria can become resistant to cephalosporins. One common mechanism is through the production of beta-lactamases, enzymes that can break down the beta-lactam ring structure of cephalosporins and other related antibiotics. This makes the drugs ineffective against the bacteria.

Another mechanism of resistance involves changes in the bacterial cell membrane or the penicillin-binding proteins (PBPs) that prevent the binding of cephalosporins to their target sites. These changes can occur due to genetic mutations or the acquisition of new genes through horizontal gene transfer.

Cephalosporin resistance is a significant public health concern, as it can limit the treatment options for bacterial infections and increase the risk of morbidity and mortality. The overuse and misuse of antibiotics are major drivers of antibiotic resistance, including cephalosporin resistance. Therefore, it is essential to use these drugs judiciously and follow proper infection prevention and control measures to prevent the spread of resistant bacteria.

Beta-lactamases are enzymes produced by certain bacteria that can break down and inactivate beta-lactam antibiotics, such as penicillins, cephalosporins, and carbapenems. This enzymatic activity makes the bacteria resistant to these antibiotics, limiting their effectiveness in treating infections caused by these organisms.

Beta-lactamases work by hydrolyzing the beta-lactam ring, a structural component of these antibiotics that is essential for their antimicrobial activity. By breaking down this ring, the enzyme renders the antibiotic ineffective against the bacterium, allowing it to continue growing and potentially causing harm.

There are different classes of beta-lactamases (e.g., Ambler Class A, B, C, and D), each with distinct characteristics and mechanisms for breaking down various beta-lactam antibiotics. The emergence and spread of bacteria producing these enzymes have contributed to the growing problem of antibiotic resistance, making it increasingly challenging to treat infections caused by these organisms.

To overcome this issue, researchers have developed beta-lactamase inhibitors, which are drugs that can bind to and inhibit the activity of these enzymes, thus restoring the effectiveness of certain beta-lactam antibiotics. Examples of such combinations include amoxicillin/clavulanate (Augmentin) and piperacillin/tazobactam (Zosyn).

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

Cephaloridine is a type of antibiotic that belongs to the class of cephalosporins. It is used for treating various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and septicemia.

Cephaloridine works by inhibiting the synthesis of the bacterial cell wall, leading to bacterial death. It is administered intramuscularly or intravenously and is known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. However, due to its potential nephrotoxicity (kidney toxicity), it has largely been replaced by other antibiotics with similar spectra of activity but better safety profiles.

It's important to note that the use of cephaloridine should be reserved for infections caused by bacteria that are resistant to other antibiotics, and its administration should be closely monitored by a healthcare professional to minimize the risk of adverse effects.

A cephalosporinase is an enzyme that can break down and inactivate cephalosporins, a group of antibiotics commonly used to treat various bacterial infections. Bacteria that produce this enzyme are referred to as "cephalosporin-resistant" or "cephalosporinase-producing" organisms. The production of cephalosporinases by bacteria can lead to treatment failures and make infections more difficult to manage.

Cephalosporins are broad-spectrum antibiotics, which means they can be effective against a wide range of bacterial species. However, some bacteria have developed resistance mechanisms, such as the production of cephalosporinases, to counteract their effects. These enzymes hydrolyze the beta-lactam ring in cephalosporins, rendering them ineffective.

There are different classes of cephalosporinases (e.g., Ambler classes A, C, and D), each with distinct characteristics and substrate profiles. Some cephalosporinases can hydrolyze a broader range of cephalosporins than others, leading to varying degrees of resistance.

To overcome cephalosporinase-mediated resistance, alternative antibiotics or combinations of antibiotics may be used. Additionally, the development of new cephalosporins with improved stability against these enzymes is an ongoing area of research in the field of antimicrobial drug discovery.

Cefotaxime is a third-generation cephalosporin antibiotic, which is used to treat a variety of bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Cefotaxime has a broad spectrum of activity and is effective against many Gram-positive and Gram-negative bacteria, including some that are resistant to other antibiotics.

Cefotaxime is often used to treat serious infections such as pneumonia, meningitis, and sepsis. It may also be used to prevent infections during surgery or in people with weakened immune systems. The drug is administered intravenously or intramuscularly, and its dosage depends on the type and severity of the infection being treated.

Like all antibiotics, cefotaxime can cause side effects, including diarrhea, nausea, vomiting, and rash. In rare cases, it may cause serious allergic reactions or damage to the kidneys or liver. It is important to follow the prescribing physician's instructions carefully when taking this medication.

Cephalexin is a type of antibiotic known as a first-generation cephalosporin. It works by interfering with the bacteria's ability to form a cell wall, which is essential for its survival. Without a functional cell wall, the bacterial cells become unstable and eventually die.

Cephalexin is effective against a wide range of gram-positive and some gram-negative bacteria, making it a useful antibiotic for treating various types of infections, such as respiratory tract infections, skin and soft tissue infections, bone and joint infections, and urinary tract infections.

Like all antibiotics, cephalexin should be used only to treat bacterial infections, as it has no effect on viral infections. It is important to take the full course of treatment as directed by a healthcare professional, even if symptoms improve before the medication is finished, to ensure that the infection is fully treated and to reduce the risk of antibiotic resistance.

Common side effects of cephalexin include nausea, diarrhea, vomiting, and stomach pain. In rare cases, more serious side effects such as allergic reactions, severe skin rashes, or liver damage may occur. It is important to seek medical attention immediately if any signs of an allergic reaction or serious side effect are experienced while taking cephalexin.

Cefixime is a third-generation cephalosporin antibiotic, which is used to treat various bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Cefixime is available as an oral suspension or tablet and is commonly prescribed for respiratory tract infections, urinary tract infections, ear infections, and skin infections.

The medical definition of Cefixime can be stated as follows:

Cefixime: A semisynthetic antibiotic derived from cephalosporin, which is used to treat a variety of bacterial infections. It has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including beta-lactamase producing strains. Cefixime is administered orally and is often prescribed for respiratory tract infections, urinary tract infections, ear infections, and skin infections. It has a long half-life and high oral bioavailability, making it a convenient option for outpatient treatment.

Common side effects of Cefixime include diarrhea, nausea, vomiting, abdominal pain, and headache. Serious side effects are rare but may include anaphylaxis, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Caution should be exercised when prescribing Cefixime to patients with a history of allergic reactions to cephalosporins or penicillins.

Beta-lactams are a class of antibiotics that include penicillins, cephalosporins, carbapenems, and monobactams. They contain a beta-lactam ring in their chemical structure, which is responsible for their antibacterial activity. The beta-lactam ring inhibits the bacterial enzymes necessary for cell wall synthesis, leading to bacterial death. Beta-lactams are commonly used to treat a wide range of bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and bone and joint infections. However, some bacteria have developed resistance to beta-lactams through the production of beta-lactamases, enzymes that can break down the beta-lactam ring and render the antibiotic ineffective. To overcome this resistance, beta-lactam antibiotics are often combined with beta-lactamase inhibitors, which protect the beta-lactam ring from degradation.

Penicillins are a group of antibiotics derived from the Penicillium fungus. They are widely used to treat various bacterial infections due to their bactericidal activity, which means they kill bacteria by interfering with the synthesis of their cell walls. The first penicillin, benzylpenicillin (also known as penicillin G), was discovered in 1928 by Sir Alexander Fleming. Since then, numerous semi-synthetic penicillins have been developed to expand the spectrum of activity and stability against bacterial enzymes that can inactivate these drugs.

Penicillins are classified into several groups based on their chemical structure and spectrum of activity:

1. Natural Penicillins (e.g., benzylpenicillin, phenoxymethylpenicillin): These have a narrow spectrum of activity, mainly targeting Gram-positive bacteria such as streptococci and staphylococci. However, they are susceptible to degradation by beta-lactamase enzymes produced by some bacteria.
2. Penicillinase-resistant Penicillins (e.g., methicillin, oxacillin, nafcillin): These penicillins resist degradation by certain bacterial beta-lactamases and are primarily used to treat infections caused by staphylococci, including methicillin-susceptible Staphylococcus aureus (MSSA).
3. Aminopenicillins (e.g., ampicillin, amoxicillin): These penicillins have an extended spectrum of activity compared to natural penicillins, including some Gram-negative bacteria such as Escherichia coli and Haemophilus influenzae. However, they are still susceptible to degradation by many beta-lactamases.
4. Antipseudomonal Penicillins (e.g., carbenicillin, ticarcillin): These penicillins have activity against Pseudomonas aeruginosa and other Gram-negative bacteria with increased resistance to other antibiotics. They are often combined with beta-lactamase inhibitors such as clavulanate or tazobactam to protect them from degradation.
5. Extended-spectrum Penicillins (e.g., piperacillin): These penicillins have a broad spectrum of activity, including many Gram-positive and Gram-negative bacteria. They are often combined with beta-lactamase inhibitors to protect them from degradation.

Penicillins are generally well-tolerated antibiotics; however, they can cause allergic reactions in some individuals, ranging from mild skin rashes to life-threatening anaphylaxis. Cross-reactivity between different penicillin classes and other beta-lactam antibiotics (e.g., cephalosporins) is possible but varies depending on the specific drugs involved.

Ceftriaxone is a third-generation cephalosporin antibiotic, which is used to treat a wide range of bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Ceftriaxone has a broad spectrum of activity and is effective against many gram-positive and gram-negative bacteria, including some that are resistant to other antibiotics.

Ceftriaxone is available in injectable form and is commonly used to treat serious infections such as meningitis, pneumonia, and sepsis. It is also used to prevent infections after surgery or trauma. The drug is generally well-tolerated, but it can cause side effects such as diarrhea, nausea, vomiting, and rash. In rare cases, it may cause serious side effects such as anaphylaxis, kidney damage, and seizures.

It's important to note that Ceftriaxone should be used only under the supervision of a healthcare professional, and that it is not recommended for use in individuals with a history of allergic reactions to cephalosporins or penicillins. Additionally, as with all antibiotics, it should be taken as directed and for the full duration of the prescribed course of treatment, even if symptoms improve before the treatment is finished.

Cephalothin is a type of antibiotic known as a first-generation cephalosporin. It is used to treat a variety of bacterial infections, including respiratory tract infections, skin and soft tissue infections, bone and joint infections, and urinary tract infections.

Cephalothin works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. It binds to specific proteins in the bacterial cell wall, causing the wall to become unstable and ultimately leading to the death of the bacterium.

Like other antibiotics, cephalothin is only effective against certain types of bacteria, and it should be used under the direction of a healthcare professional. It is important to take the full course of treatment as directed, even if symptoms improve, to ensure that the infection is fully treated and to reduce the risk of developing antibiotic resistance.

Common side effects of cephalothin include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. More serious side effects may include allergic reactions, kidney damage, and seizures. It is important to inform your healthcare provider of any medical conditions you have or medications you are taking before starting treatment with cephalothin.

Cefmenoxime is a second-generation cephalosporin antibiotic, which is used to treat various bacterial infections. It works by inhibiting the synthesis of the bacterial cell wall. Cefmenoxime has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including some strains that are resistant to other antibiotics.

Common indications for cefmenoxime include respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and intra-abdominal infections. It is also used as a prophylactic agent during surgery to reduce the risk of postoperative infections.

Cefmenoxime is usually administered intravenously or intramuscularly, and its dosage may vary depending on the type and severity of the infection, as well as the patient's age and renal function. Common side effects of cefmenoxime include gastrointestinal symptoms such as diarrhea, nausea, and vomiting, as well as allergic reactions such as rash, itching, and hives.

It is important to note that the use of antibiotics should be based on a careful assessment of the patient's condition and the susceptibility of the infecting organism. Overuse or misuse of antibiotics can lead to the development of antibiotic resistance, which can make subsequent infections more difficult to treat.

Beta-lactam resistance is a type of antibiotic resistance in which bacteria have developed the ability to inactivate or circumvent the action of beta-lactam antibiotics. Beta-lactams are a class of antibiotics that include penicillins, cephalosporins, carbapenems, and monobactams. They work by binding to and inhibiting the activity of enzymes called penicillin-binding proteins (PBPs), which are essential for bacterial cell wall synthesis.

Bacteria can develop beta-lactam resistance through several mechanisms:

1. Production of beta-lactamases: These are enzymes that bacteria produce to break down and inactivate beta-lactam antibiotics. Some bacteria have acquired genes that encode for beta-lactamases that can hydrolyze and destroy the beta-lactam ring, rendering the antibiotic ineffective.
2. Alteration of PBPs: Bacteria can also develop mutations in their PBPs that make them less susceptible to beta-lactams. These alterations can reduce the affinity of PBPs for beta-lactams or change their conformation, preventing the antibiotic from binding effectively.
3. Efflux pumps: Bacteria can also develop efflux pumps that actively pump beta-lactam antibiotics out of the cell, reducing their intracellular concentration and limiting their effectiveness.
4. Biofilm formation: Some bacteria can form biofilms, which are communities of microorganisms that adhere to surfaces and are encased in a protective matrix. Biofilms can make bacteria more resistant to beta-lactams by preventing the antibiotics from reaching their targets.

Beta-lactam resistance is a significant public health concern because it limits the effectiveness of these important antibiotics. The overuse and misuse of beta-lactams have contributed to the emergence and spread of resistant bacteria, making it essential to use these antibiotics judiciously and develop new strategies to combat bacterial resistance.

Cefotiam is a type of antibiotic known as a cephalosporin, which is used to treat various bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, leading to bacterial cell death. Cefotiam has a broad spectrum of activity and is effective against many gram-positive and gram-negative bacteria.

Here is the medical definition of 'Cefotiam':

Cefotiam is a semisynthetic, broad-spectrum, beta-lactam antibiotic belonging to the cephalosporin class. It has activity against both gram-positive and gram-negative bacteria, including many strains that are resistant to other antibiotics. Cefotiam inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to bacterial cell death.

Cefotiam is available in various formulations, including intravenous (IV) and intramuscular (IM) injections, for the treatment of a wide range of infections, such as:

* Lower respiratory tract infections (e.g., pneumonia, bronchitis)
* Urinary tract infections (e.g., pyelonephritis, cystitis)
* Skin and soft tissue infections (e.g., cellulitis, wound infections)
* Bone and joint infections (e.g., osteomyelitis, septic arthritis)
* Intra-abdominal infections (e.g., peritonitis, appendicitis)
* Septicemia (bloodstream infections)

Cefotiam is generally well tolerated, but like other antibiotics, it can cause side effects, including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea), skin rashes, and allergic reactions. In rare cases, cefotiam may cause serious adverse effects, such as seizures, interstitial nephritis, or hemorrhagicystitis. It should be used with caution in patients with a history of allergy to beta-lactam antibiotics, impaired renal function, or a history of seizure disorders.

It is essential to complete the full course of treatment as prescribed by a healthcare professional, even if symptoms improve, to ensure that the infection is entirely eradicated and to reduce the risk of developing antibiotic resistance.

Enterobacteriaceae is a family of gram-negative, rod-shaped bacteria that are commonly found in the intestines of humans and animals. Many species within this family are capable of causing various types of infections, particularly in individuals with weakened immune systems. Some common examples of Enterobacteriaceae include Escherichia coli (E. coli), Klebsiella pneumoniae, Proteus mirabilis, and Salmonella enterica.

These bacteria are typically characterized by their ability to ferment various sugars and produce acid and gas as byproducts. They can also be distinguished by their biochemical reactions, such as their ability to produce certain enzymes or resist specific antibiotics. Infections caused by Enterobacteriaceae can range from mild to severe, depending on the species involved and the overall health of the infected individual.

Some infections caused by Enterobacteriaceae include urinary tract infections, pneumonia, bloodstream infections, and foodborne illnesses. Proper hygiene, such as handwashing and safe food handling practices, can help prevent the spread of these bacteria and reduce the risk of infection.

Ceftazidime is a third-generation cephalosporin antibiotic, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, leading to bacterial cell death. Ceftazidime has a broad spectrum of activity and is effective against many Gram-negative and some Gram-positive bacteria.

It is often used to treat serious infections such as pneumonia, urinary tract infections, and sepsis, particularly when they are caused by antibiotic-resistant bacteria. Ceftazidime is also commonly used in combination with other antibiotics to treat complicated abdominal infections, bone and joint infections, and hospital-acquired pneumonia.

Like all antibiotics, ceftazidime can cause side effects, including diarrhea, nausea, vomiting, and allergic reactions. It may also affect the kidneys and should be used with caution in patients with impaired renal function. Ceftazidime is available in both intravenous (IV) and oral forms.

Ceftizoxime is a type of antibiotic known as a third-generation cephalosporin. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Ceftizoxime is effective against a wide range of gram-positive and gram-negative bacteria, including many that are resistant to other antibiotics.

It is commonly used to treat various types of infections, such as pneumonia, urinary tract infections, skin infections, and intra-abdominal infections. Ceftizoxime is available in both intravenous (IV) and oral forms, although the IV form is more commonly used in clinical practice.

Like all antibiotics, ceftizoxime should be used only to treat bacterial infections, as it has no effect on viral infections. Overuse or misuse of antibiotics can lead to the development of antibiotic resistance, which makes it more difficult to treat infections in the future.

It is important to note that ceftizoxime should only be used under the supervision of a healthcare provider, who will determine the appropriate dosage and duration of treatment based on the patient's individual needs and medical history.

Bacteria are single-celled microorganisms that are among the earliest known life forms on Earth. They are typically characterized as having a cell wall and no membrane-bound organelles. The majority of bacteria have a prokaryotic organization, meaning they lack a nucleus and other membrane-bound organelles.

Bacteria exist in diverse environments and can be found in every habitat on Earth, including soil, water, and the bodies of plants and animals. Some bacteria are beneficial to their hosts, while others can cause disease. Beneficial bacteria play important roles in processes such as digestion, nitrogen fixation, and biogeochemical cycling.

Bacteria reproduce asexually through binary fission or budding, and some species can also exchange genetic material through conjugation. They have a wide range of metabolic capabilities, with many using organic compounds as their source of energy, while others are capable of photosynthesis or chemosynthesis.

Bacteria are highly adaptable and can evolve rapidly in response to environmental changes. This has led to the development of antibiotic resistance in some species, which poses a significant public health challenge. Understanding the biology and behavior of bacteria is essential for developing strategies to prevent and treat bacterial infections and diseases.

Cephradine is a type of antibiotic known as a first-generation cephalosporin. It is used to treat a variety of bacterial infections, including respiratory tract infections, skin and soft tissue infections, bone and joint infections, and genitourinary tract infections. Cephradine works by interfering with the bacteria's ability to form a cell wall, which leads to the death of the bacteria.

Cephradine is available in oral (by mouth) and intravenous (into a vein) forms. Common side effects of cephradine include diarrhea, nausea, vomiting, and stomach pain. More serious side effects can occur, such as allergic reactions, seizures, and severe skin reactions. It is important to take cephradine exactly as directed by a healthcare professional and to inform them of any medical conditions or medications being taken that could interact with the antibiotic.

Enterobacter is a genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, including in soil, water, and the gastrointestinal tracts of humans and animals. These bacteria are members of the family Enterobacteriaceae and are known to cause a variety of infections in humans, particularly in healthcare settings.

Enterobacter species are capable of causing a range of infections, including urinary tract infections, pneumonia, bacteremia, and wound infections. They are often resistant to multiple antibiotics, which can make treatment challenging. Infections with Enterobacter are typically treated with broad-spectrum antibiotics that are effective against gram-negative bacteria.

It's worth noting that while Enterobacter species can cause infections, they are also a normal part of the microbiota found in the human gut and usually do not cause harm in healthy individuals. However, if the bacterium enters the bloodstream or other sterile sites in the body, it can cause infection and illness.

Cefazolin is a type of antibiotic known as a cephalosporin, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria are not able to grow and multiply, and are eventually destroyed by the body's immune system.

Cefazolin is commonly used to treat infections of the skin, bones, joints, heart, lungs, and urinary tract. It may also be used to prevent infection during surgery. Like all antibiotics, cefazolin is only effective against certain types of bacteria, so it is important to know the specific type of bacteria causing an infection before using this medication.

Cefazolin is usually given as an injection into a vein or muscle, and may be administered in a hospital setting or at home with proper training. The dosage and duration of treatment will depend on the severity and location of the infection, as well as the patient's overall health status.

As with any medication, cefazolin can cause side effects, including diarrhea, nausea, vomiting, headache, and rash. In rare cases, it may also cause serious side effects such as allergic reactions, kidney damage, or abnormal blood clotting. It is important to report any unusual symptoms to a healthcare provider promptly.

It is essential to complete the full course of treatment with cefazolin, even if symptoms improve, to ensure that the infection is fully treated and to reduce the risk of antibiotic resistance.

"Klebsiella pneumoniae" is a medical term that refers to a type of bacteria belonging to the family Enterobacteriaceae. It's a gram-negative, encapsulated, non-motile, rod-shaped bacterium that can be found in various environments, including soil, water, and the gastrointestinal tracts of humans and animals.

"Klebsiella pneumoniae" is an opportunistic pathogen that can cause a range of infections, particularly in individuals with weakened immune systems or underlying medical conditions. It's a common cause of healthcare-associated infections, such as pneumonia, urinary tract infections, bloodstream infections, and wound infections.

The bacterium is known for its ability to produce a polysaccharide capsule that makes it resistant to phagocytosis by white blood cells, allowing it to evade the host's immune system. Additionally, "Klebsiella pneumoniae" has developed resistance to many antibiotics, making infections caused by this bacterium difficult to treat and a growing public health concern.

Microbial drug resistance is a significant medical issue that refers to the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to withstand or survive exposure to drugs or medications designed to kill them or limit their growth. This phenomenon has become a major global health concern, particularly in the context of bacterial infections, where it is also known as antibiotic resistance.

Drug resistance arises due to genetic changes in microorganisms that enable them to modify or bypass the effects of antimicrobial agents. These genetic alterations can be caused by mutations or the acquisition of resistance genes through horizontal gene transfer. The resistant microbes then replicate and multiply, forming populations that are increasingly difficult to eradicate with conventional treatments.

The consequences of drug-resistant infections include increased morbidity, mortality, healthcare costs, and the potential for widespread outbreaks. Factors contributing to the emergence and spread of microbial drug resistance include the overuse or misuse of antimicrobials, poor infection control practices, and inadequate surveillance systems.

To address this challenge, it is crucial to promote prudent antibiotic use, strengthen infection prevention and control measures, develop new antimicrobial agents, and invest in research to better understand the mechanisms underlying drug resistance.

Penicillinase is an enzyme produced by some bacteria that can inactivate penicillin and other beta-lactam antibiotics by breaking down the beta-lactam ring, which is essential for their antimicrobial activity. Bacteria that produce penicillinase are resistant to penicillin and related antibiotics. Penicillinase-resistant penicillins, such as methicillin and oxacillin, have been developed to overcome this form of bacterial resistance.

Aztreonam is a monobactam antibiotic, which is a type of antibacterial drug used to treat infections caused by bacteria. It works by interfering with the ability of bacterial cells to form cell walls, leading to their death. Aztreonam is specifically active against certain types of gram-negative bacteria, including Pseudomonas aeruginosa and Escherichia coli.

Aztreonam is available in various forms, including injectable solutions and inhaled powder, for use in different clinical settings. It is often used to treat serious infections that have not responded to other antibiotics or that are caused by bacteria that are resistant to other antibiotics.

Like all antibiotics, aztreonam can cause side effects, including nausea, vomiting, diarrhea, and headache. It may also cause allergic reactions in some people, particularly those with a history of allergies to other antibiotics. It is important to use aztreonam only as directed by a healthcare provider and to report any unusual symptoms or side effects promptly.

Enterobacteriaceae are a large family of gram-negative bacteria that are commonly found in the human gut and surrounding environment. Infections caused by Enterobacteriaceae can occur when these bacteria enter parts of the body where they are not normally present, such as the bloodstream, urinary tract, or abdominal cavity.

Enterobacteriaceae infections can cause a range of symptoms depending on the site of infection. For example:

* Urinary tract infections (UTIs) caused by Enterobacteriaceae may cause symptoms such as frequent urination, pain or burning during urination, and lower abdominal pain.
* Bloodstream infections (bacteremia) caused by Enterobacteriaceae can cause fever, chills, and sepsis, a potentially life-threatening condition characterized by a whole-body inflammatory response to infection.
* Pneumonia caused by Enterobacteriaceae may cause cough, chest pain, and difficulty breathing.
* Intra-abdominal infections (such as appendicitis or diverticulitis) caused by Enterobacteriaceae can cause abdominal pain, fever, and changes in bowel habits.

Enterobacteriaceae infections are typically treated with antibiotics, but the increasing prevalence of antibiotic-resistant strains of these bacteria has made treatment more challenging in recent years. Preventing the spread of Enterobacteriaceae in healthcare settings and promoting good hygiene practices can help reduce the risk of infection.

Cefoxitin is a type of antibiotic known as a cephamycin, which is a subclass of the larger group of antibiotics called cephalosporins. Cephalosporins are bactericidal agents that inhibit bacterial cell wall synthesis by binding to and disrupting the function of penicillin-binding proteins (PBPs).

Cefoxitin has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including many strains that are resistant to other antibiotics. It is commonly used to treat infections caused by susceptible organisms such as:

* Staphylococcus aureus (including methicillin-resistant S. aureus or MRSA)
* Streptococcus pneumoniae
* Escherichia coli
* Klebsiella spp.
* Proteus mirabilis
* Bacteroides fragilis and other anaerobic bacteria

Cefoxitin is available in both intravenous (IV) and intramuscular (IM) formulations, and it is typically administered every 6 to 8 hours. The drug is generally well tolerated, but potential side effects include gastrointestinal symptoms such as diarrhea, nausea, and vomiting, as well as allergic reactions, including rash, pruritus, and anaphylaxis.

It's important to note that the use of antibiotics should be based on the results of bacterial cultures and susceptibility testing whenever possible, to ensure appropriate therapy and minimize the development of antibiotic resistance.

Gram-negative bacteria are a type of bacteria that do not retain the crystal violet stain used in the Gram staining method, a standard technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This method was developed by Hans Christian Gram in 1884.

The primary characteristic distinguishing Gram-negative bacteria from Gram-positive bacteria is the composition and structure of their cell walls:

1. Cell wall: Gram-negative bacteria have a thin peptidoglycan layer, making it more susceptible to damage and less rigid compared to Gram-positive bacteria.
2. Outer membrane: They possess an additional outer membrane that contains lipopolysaccharides (LPS), which are endotoxins that can trigger strong immune responses in humans and animals. The outer membrane also contains proteins, known as porins, which form channels for the passage of molecules into and out of the cell.
3. Periplasm: Between the inner and outer membranes lies a compartment called the periplasm, where various enzymes and other molecules are located.

Some examples of Gram-negative bacteria include Escherichia coli (E. coli), Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella enterica, Shigella spp., and Neisseria meningitidis. These bacteria are often associated with various infections, such as urinary tract infections, pneumonia, sepsis, and meningitis. Due to their complex cell wall structure, Gram-negative bacteria can be more resistant to certain antibiotics, making them a significant concern in healthcare settings.

Cefamandole is a second-generation cephalosporin antibiotic, which is a type of antibacterial medication used to treat various infections caused by bacteria. It works by interfering with the ability of bacteria to form cell walls, resulting in weakening and eventual death of the bacterial cells.

Cefamandole has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, making it useful for treating a variety of infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and septicemia.

Like other cephalosporins, cefamandole is generally well-tolerated and has a low incidence of serious side effects. However, it can cause gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as allergic reactions in some people. It may also interact with other medications, so it's important to inform your healthcare provider of all the medications you are taking before starting cefamandole therapy.

It is important to note that antibiotics should only be used to treat bacterial infections and not viral infections, as they are not effective against viruses and can contribute to the development of antibiotic resistance.

Penicillin resistance is the ability of certain bacteria to withstand the antibacterial effects of penicillin, a type of antibiotic. This occurs when these bacteria have developed mechanisms that prevent penicillin from binding to and inhibiting the function of their cell wall biosynthesis proteins, particularly the enzyme transpeptidase.

One common mechanism of penicillin resistance is the production of beta-lactamases, enzymes that can hydrolyze and inactivate the beta-lactam ring structure present in penicillin and other related antibiotics. Another mechanism involves alterations in the bacterial cell wall that prevent penicillin from binding to its target proteins.

Penicillin resistance is a significant concern in clinical settings, as it can limit treatment options for bacterial infections and may necessitate the use of more potent or toxic antibiotics. It is important to note that misuse or overuse of antibiotics can contribute to the development and spread of antibiotic-resistant bacteria, including those resistant to penicillin.

Cephamycins are a subclass of cephalosporin antibiotics, which are derived from the fungus Acremonium species. They have a similar chemical structure to other cephalosporins but have an additional methoxy group on their side chain that makes them more resistant to beta-lactamases, enzymes produced by some bacteria that can inactivate other cephalosporins and penicillins.

Cephamycins are primarily used to treat infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, Proteus species, and Enterobacter species. They have a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, making them useful for treating a variety of infections.

The two main cephamycins that are used clinically are cefoxitin and cefotetan. Cefoxitin is often used to treat intra-abdominal infections, pelvic inflammatory disease, and skin and soft tissue infections. Cefotetan is primarily used for the treatment of surgical prophylaxis, gynecological infections, and pneumonia.

Like other cephalosporins, cephamycins can cause allergic reactions, including rashes, hives, and anaphylaxis. They should be used with caution in patients who have a history of allergies to penicillin or other beta-lactam antibiotics. Additionally, cephamycins can disrupt the normal gut flora, leading to secondary infections such as Clostridioides difficile (C. diff) diarrhea.

Bacterial drug resistance is a type of antimicrobial resistance that occurs when bacteria evolve the ability to survive and reproduce in the presence of drugs (such as antibiotics) that would normally kill them or inhibit their growth. This can happen due to various mechanisms, including genetic mutations or the acquisition of resistance genes from other bacteria.

As a result, bacterial infections may become more difficult to treat, requiring higher doses of medication, alternative drugs, or longer treatment courses. In some cases, drug-resistant infections can lead to serious health complications, increased healthcare costs, and higher mortality rates.

Examples of bacterial drug resistance include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and multidrug-resistant tuberculosis (MDR-TB). Preventing the spread of bacterial drug resistance is crucial for maintaining effective treatments for infectious diseases.

Klebsiella is a genus of Gram-negative, facultatively anaerobic, encapsulated, non-motile, rod-shaped bacteria that are part of the family Enterobacteriaceae. They are commonly found in the normal microbiota of the mouth, skin, and intestines, but can also cause various types of infections, particularly in individuals with weakened immune systems.

Klebsiella pneumoniae is the most common species and can cause pneumonia, urinary tract infections, bloodstream infections, and wound infections. Other Klebsiella species, such as K. oxytoca, can also cause similar types of infections. These bacteria are resistant to many antibiotics, making them difficult to treat and a significant public health concern.

Cefaclor is a type of antibiotic known as a second-generation cephalosporin. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria eventually die. Cefaclor is effective against a wide range of gram-positive and gram-negative bacteria, making it a broad-spectrum antibiotic.

Cefaclor is used to treat various types of bacterial infections, including respiratory tract infections (such as bronchitis and pneumonia), ear infections, skin infections, and urinary tract infections. It is available in both oral and intravenous forms.

Like all antibiotics, cefaclor should be used only to treat bacterial infections, as it is not effective against viral infections such as the common cold or flu. Overuse of antibiotics can lead to the development of antibiotic-resistant bacteria, which can make future infections more difficult to treat. It is important to take cefaclor exactly as directed by a healthcare professional and to complete the full course of treatment, even if symptoms improve before all of the medication has been taken.

Cefoperazone is a type of antibiotic known as a cephalosporin, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria are not able to grow and multiply, and are eventually destroyed by the body's immune system.

Cefoperazone is often used to treat infections of the respiratory tract, urinary tract, skin, and soft tissues. It may also be used to prevent infections during surgery. Like all antibiotics, cefoperazone should only be used under the direction of a healthcare professional, as misuse can lead to the development of drug-resistant bacteria.

It is important to note that cefoperazone, like other antibiotics, can have side effects, including gastrointestinal symptoms such as diarrhea, nausea, and vomiting. It may also cause allergic reactions in some people. If you experience any unusual symptoms while taking cefoperazone, it is important to contact your healthcare provider right away.

Carbapenems are a class of broad-spectrum beta-lactam antibiotics, which are used to treat severe infections caused by bacteria that are resistant to other antibiotics. They have a similar chemical structure to penicillins and cephalosporins but are more resistant to the enzymes produced by bacteria that can inactivate these other antibiotics. Carbapenems are often reserved for use in serious infections caused by multidrug-resistant organisms, and they are typically given intravenously in a hospital setting. Examples of carbapenems include imipenem, meropenem, doripenem, and ertapenem.

Cefmetazole is a second-generation cephalosporin antibiotic, which is used to treat various bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, leading to bacterial cell death. Cefmetazole has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including many strains that are resistant to other antibiotics.

Common side effects of cefmetazole include diarrhea, nausea, vomiting, and headache. More serious side effects can include allergic reactions, seizures, and changes in blood cell counts or liver function. As with all antibiotics, it is important to take cefmetazole exactly as directed by a healthcare provider, and to complete the full course of treatment even if symptoms improve.

Cefadroxil is a type of antibiotic known as a cephalosporin. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria eventually die. Cefadroxil is used to treat a variety of infections caused by bacteria, including skin infections, ear infections, and urinary tract infections.

Cefadroxil is available as a prescription medication and is typically taken by mouth in the form of a tablet or liquid suspension. It is usually taken one to two times a day, depending on the severity of the infection and the individual patient's needs.

As with all antibiotics, it is important to take cefadroxil exactly as directed by your healthcare provider and to finish the entire course of treatment, even if you start to feel better. This will help ensure that the infection is fully treated and reduce the risk of the bacteria becoming resistant to the antibiotic.

Some common side effects of cefadroxil include nausea, vomiting, diarrhea, and stomach pain. In rare cases, more serious side effects may occur, such as an allergic reaction or severe skin reactions. If you experience any unusual symptoms while taking cefadroxil, it is important to contact your healthcare provider right away.

Klebsiella infections are caused by bacteria called Klebsiella spp., with the most common species being Klebsiella pneumoniae. These gram-negative, encapsulated bacilli are normal inhabitants of the human gastrointestinal tract and upper respiratory tract but can cause various types of infections when they spread to other body sites.

Commonly, Klebsiella infections include:

1. Pneumonia: This is a lung infection that can lead to symptoms like cough, chest pain, difficulty breathing, and fever. It often affects people with weakened immune systems, chronic lung diseases, or those who are hospitalized.

2. Urinary tract infections (UTIs): Klebsiella can cause UTIs, particularly in individuals with compromised urinary tracts, such as catheterized patients or those with structural abnormalities. Symptoms may include pain, burning during urination, frequent urges to urinate, and lower abdominal or back pain.

3. Bloodstream infections (bacteremia/septicemia): When Klebsiella enters the bloodstream, it can cause bacteremia or septicemia, which can lead to sepsis, a life-threatening condition characterized by an overwhelming immune response to infection. Symptoms may include fever, chills, rapid heart rate, and rapid breathing.

4. Wound infections: Klebsiella can infect wounds, particularly in patients with open surgical wounds or traumatic injuries. Infected wounds may display redness, swelling, pain, pus discharge, and warmth.

5. Soft tissue infections: These include infections of the skin and underlying soft tissues, such as cellulitis and abscesses. Symptoms can range from localized redness, swelling, and pain to systemic symptoms like fever and malaise.

Klebsiella infections are increasingly becoming difficult to treat due to their resistance to multiple antibiotics, including carbapenems, which has led to the term "carbapenem-resistant Enterobacteriaceae" (CRE) or "carbapenem-resistant Klebsiella pneumoniae" (CRKP). These infections often require the use of last-resort antibiotics like colistin and tigecycline. Infection prevention measures, such as contact precautions, hand hygiene, and environmental cleaning, are crucial to controlling the spread of Klebsiella in healthcare settings.

Moxalactam is not a medical condition but actually an antibiotic medication. It is a type of beta-lactam antibiotic, specifically a fourth-generation cephalosporin, which is used to treat various bacterial infections. Moxalactam has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including many that are resistant to other antibiotics.

Moxalactam works by inhibiting the synthesis of the bacterial cell wall, leading to bacterial death. It is commonly used to treat intra-abdominal infections, urinary tract infections, pneumonia, and sepsis, among other conditions. As with any medication, moxalactam can have side effects, including gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as allergic reactions and changes in liver function tests. It is important to use antibiotics only when necessary and under the guidance of a healthcare professional to minimize the development of antibiotic resistance.

Ampicillin is a penicillin-type antibiotic used to treat a wide range of bacterial infections. It works by interfering with the ability of bacteria to form cell walls, which are essential for their survival. This causes the bacterial cells to become unstable and eventually die.

The medical definition of Ampicillin is:

"A semi-synthetic penicillin antibiotic, derived from the Penicillium mold. It is used to treat a variety of infections caused by susceptible gram-positive and gram-negative bacteria. Ampicillin is effective against both aerobic and anaerobic organisms. It is commonly used to treat respiratory tract infections, urinary tract infections, meningitis, and endocarditis."

It's important to note that Ampicillin is not effective against infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or other bacteria that have developed resistance to penicillins. Additionally, overuse of antibiotics like Ampicillin can lead to the development of antibiotic resistance, which is a significant public health concern.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Multiple bacterial drug resistance (MDR) is a medical term that refers to the resistance of multiple strains of bacteria to several antibiotics or antimicrobial agents. This means that these bacteria have developed mechanisms that enable them to survive and multiply despite being exposed to drugs that were previously effective in treating infections caused by them.

MDR is a significant public health concern because it limits the treatment options available for bacterial infections, making them more difficult and expensive to treat. In some cases, MDR bacteria may cause severe or life-threatening infections that are resistant to all available antibiotics, leaving doctors with few or no effective therapeutic options.

MDR can arise due to various mechanisms, including the production of enzymes that inactivate antibiotics, changes in bacterial cell membrane permeability that prevent antibiotics from entering the bacteria, and the development of efflux pumps that expel antibiotics out of the bacteria. The misuse or overuse of antibiotics is a significant contributor to the emergence and spread of MDR bacteria.

Preventing and controlling the spread of MDR bacteria requires a multifaceted approach, including the judicious use of antibiotics, infection control measures, surveillance, and research into new antimicrobial agents.

Isoelectric focusing (IEF) is a technique used in electrophoresis, which is a method for separating proteins or other molecules based on their electrical charges. In IEF, a mixture of ampholytes (molecules that can carry both positive and negative charges) is used to create a pH gradient within a gel matrix. When an electric field is applied, the proteins or molecules migrate through the gel until they reach the point in the gradient where their net charge is zero, known as their isoelectric point (pI). At this point, they focus into a sharp band and stop moving, resulting in a highly resolved separation of the different components based on their pI. This technique is widely used in protein research for applications such as protein identification, characterization, and purification.

'Enterobacter cloacae' is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, including in soil, water, and the gastrointestinal tracts of humans and animals. They are part of the family Enterobacteriaceae and can cause various types of infections in humans, particularly in individuals with weakened immune systems or underlying medical conditions.

E. cloacae is known to be an opportunistic pathogen, which means that it typically does not cause disease in healthy people but can take advantage of a weakened host to cause infection. It can cause a range of infections, including urinary tract infections, pneumonia, bacteremia (bloodstream infections), and wound infections.

E. cloacae is often resistant to multiple antibiotics, which can make treatment challenging. In recent years, there has been an increase in the number of E. cloacae isolates that are resistant to carbapenems, a class of antibiotics that are typically reserved for treating serious infections caused by multidrug-resistant bacteria. This has led to concerns about the potential for untreatable infections caused by this organism.

Cefotetan is a type of antibiotic known as a cephalosporin, which is used to treat various bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, leading to the death of the bacteria. Cefotetan has a broad spectrum of activity and is effective against many different types of gram-positive and gram-negative bacteria.

Cefotetan is often used to treat intra-abdominal infections, gynecological infections, skin and soft tissue infections, and bone and joint infections. It is administered intravenously or intramuscularly, and the dosage and duration of treatment will depend on the type and severity of the infection being treated.

Like all antibiotics, cefotetan can cause side effects, including diarrhea, nausea, vomiting, and allergic reactions. It may also increase the risk of bleeding, particularly in patients with impaired kidney function or those taking blood thinners. Therefore, it is important to be closely monitored by a healthcare provider while taking this medication.

Penicillin G is a type of antibiotic that belongs to the class of medications called penicillins. It is a natural antibiotic derived from the Penicillium fungus and is commonly used to treat a variety of bacterial infections. Penicillin G is active against many gram-positive bacteria, as well as some gram-negative bacteria.

Penicillin G is available in various forms, including an injectable solution and a powder for reconstitution into a solution. It works by interfering with the ability of bacteria to form a cell wall, which ultimately leads to bacterial death. Penicillin G is often used to treat serious infections that cannot be treated with other antibiotics, such as endocarditis (inflammation of the inner lining of the heart), pneumonia, and meningitis (inflammation of the membranes surrounding the brain and spinal cord).

It's important to note that Penicillin G is not commonly used for topical or oral treatment due to its poor absorption in the gastrointestinal tract and instability in acidic environments. Additionally, as with all antibiotics, Penicillin G should be used under the guidance of a healthcare professional to ensure appropriate use and to reduce the risk of antibiotic resistance.

Bacterial infections are caused by the invasion and multiplication of bacteria in or on tissues of the body. These infections can range from mild, like a common cold, to severe, such as pneumonia, meningitis, or sepsis. The symptoms of a bacterial infection depend on the type of bacteria invading the body and the area of the body that is affected.

Bacteria are single-celled microorganisms that can live in many different environments, including in the human body. While some bacteria are beneficial to humans and help with digestion or protect against harmful pathogens, others can cause illness and disease. When bacteria invade the body, they can release toxins and other harmful substances that damage tissues and trigger an immune response.

Bacterial infections can be treated with antibiotics, which work by killing or inhibiting the growth of bacteria. However, it is important to note that misuse or overuse of antibiotics can lead to antibiotic resistance, making treatment more difficult. It is also essential to complete the full course of antibiotics as prescribed, even if symptoms improve, to ensure that all bacteria are eliminated and reduce the risk of recurrence or development of antibiotic resistance.

I'm sorry for any confusion, but "Cephaloglycin" is not a recognized or established medical term or drug name. It seems that there might be a misunderstanding or a spelling mistake in your query. Cephalosporins are a group of antibiotics commonly used to treat various bacterial infections, but I cannot find any specific information related to "Cephaloglycin." If you have more context or details, I'd be happy to help further.

Cefuroxime is a type of antibiotic known as a cephalosporin, which is used to treat a variety of bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. Without a functional cell wall, the bacteria are unable to grow and multiply, and are eventually destroyed by the body's immune system.

Cefuroxime is effective against many different types of bacteria, including both Gram-positive and Gram-negative organisms. It is often used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, and bone and joint infections.

Like all antibiotics, cefuroxime should be used only under the direction of a healthcare provider, and it is important to take the full course of treatment as prescribed, even if symptoms improve before the medication is finished. Misuse of antibiotics can lead to the development of drug-resistant bacteria, which are more difficult to treat and can pose a serious threat to public health.

Clavulanic acid is a type of beta-lactamase inhibitor, which is a compound that is used to increase the effectiveness of certain antibiotics. It works by preventing the breakdown of beta-lactam antibiotics (such as penicillins and cephalosporins) by bacterial enzymes called beta-lactamases. This allows the antibiotic to remain active against the bacteria for a longer period of time, increasing its ability to kill the bacteria and treat the infection.

Clavulanic acid is often combined with amoxicillin in a medication called Augmentin, which is used to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It may also be used in other combinations with other beta-lactam antibiotics.

Like all medications, clavulanic acid can have side effects, including gastrointestinal symptoms such as diarrhea, nausea, and vomiting. It may also cause allergic reactions in some people, particularly those who are allergic to penicillin or other beta-lactam antibiotics. It is important to follow the instructions of a healthcare provider when taking clavulanic acid or any medication.

Cross infection, also known as cross-contamination, is the transmission of infectious agents or diseases between patients in a healthcare setting. This can occur through various means such as contaminated equipment, surfaces, hands of healthcare workers, or the air. It is an important concern in medical settings and measures are taken to prevent its occurrence, including proper hand hygiene, use of personal protective equipment (PPE), environmental cleaning and disinfection, and safe injection practices.

I'm sorry for any confusion, but "Cefatrizine" does not appear to be a valid medical term or a recognized medication in modern medical literature. It is possible that there is a spelling error or typo in the term you are looking for. Please double-check the spelling and try again. If you meant to search for a different term, I'd be happy to help if you provide me with the correct one.

A lactam is a cyclic amide compound containing a carbonyl group (a double-bonded carbon atom) and a nitrogen atom. The name "lactam" is derived from the fact that these compounds are structurally similar to lactones, which are cyclic esters, but with an amide bond instead of an ester bond.

Lactams can be found in various natural and synthetic compounds, including some antibiotics such as penicillin and cephalosporins. These antibiotics contain a four-membered lactam ring (known as a β-lactam) that is essential for their biological activity. The β-lactam ring makes these compounds highly reactive, allowing them to inhibit bacterial cell wall synthesis and thus kill the bacteria.

In summary, lactams are cyclic amide compounds with a carbonyl group and a nitrogen atom in the ring structure. They can be found in various natural and synthetic compounds, including some antibiotics such as penicillin and cephalosporins.

Penicillanic acid is not a term that has a widely accepted or established medical definition in the context of human medicine or clinical practice. It is a chemical compound that is a derivative of penicillin, an antibiotic produced by certain types of mold. Penicillanic acid is a breakdown product of penicillin and is not itself used as a medication.

In chemistry, penicillanic acid is a organic compound with the formula (CH3)2C6H5COOH. It is a derivative of benzene and has a carboxylic acid group and a five-membered ring containing a sulfur atom and a double bond, which is a characteristic feature of penicillin and its derivatives.

It's important to note that while penicillanic acid may have relevance in the context of chemistry or microbiology research, it does not have a direct medical definition or application in clinical medicine.

Cloxacillin is a type of antibiotic known as a penicillinase-resistant penicillin. It is used to treat infections caused by bacteria that are resistant to other types of penicillins. Cloxacillin works by interfering with the ability of the bacterial cell wall to grow and multiply, ultimately leading to the death of the bacterium.

Cloxacillin is often used to treat skin infections, pneumonia, and other respiratory tract infections. It is available in various forms, including tablets, capsules, and powder for injection. As with all antibiotics, it is important to take cloxacillin exactly as directed by a healthcare provider, and to complete the full course of treatment, even if symptoms improve before all of the medication has been taken.

Like other penicillins, cloxacillin can cause allergic reactions in some people. It may also interact with other medications, so it is important to inform a healthcare provider of all other medications being taken before starting cloxacillin.

Gonorrhea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae, also known as "gono" bacteria. It can infect various parts of the body including the genitals, rectum, and throat. The bacteria are typically transmitted through sexual contact with an infected person.

Symptoms may vary but often include abnormal discharge from the genitals or rectum, painful or burning sensations during urination, and in women, vaginal bleeding between periods. However, many people with gonorrhea do not develop symptoms, making it essential to get tested regularly if you are sexually active with multiple partners or have unprotected sex.

If left untreated, gonorrhea can lead to severe complications such as pelvic inflammatory disease (PID) in women and epididymitis in men, which may result in infertility. In rare cases, it can spread to the bloodstream and cause life-threatening conditions like sepsis.

Gonorrhea is curable with appropriate antibiotic treatment; however, drug-resistant strains of the bacteria have emerged, making accurate diagnosis and effective treatment increasingly challenging. Prevention methods include using condoms during sexual activity and practicing safe sex habits.

A Structure-Activity Relationship (SAR) in the context of medicinal chemistry and pharmacology refers to the relationship between the chemical structure of a drug or molecule and its biological activity or effect on a target protein, cell, or organism. SAR studies aim to identify patterns and correlations between structural features of a compound and its ability to interact with a specific biological target, leading to a desired therapeutic response or undesired side effects.

By analyzing the SAR, researchers can optimize the chemical structure of lead compounds to enhance their potency, selectivity, safety, and pharmacokinetic properties, ultimately guiding the design and development of novel drugs with improved efficacy and reduced toxicity.

Neisseria gonorrhoeae is a species of gram-negative, aerobic diplococcus that is the etiologic agent of gonorrhea, a sexually transmitted infection. It is commonly found in the mucous membranes of the reproductive tract, including the cervix, urethra, and rectum, as well as the throat and eyes. The bacterium can cause a range of symptoms, including discharge, burning during urination, and, in women, abnormal menstrual bleeding. If left untreated, it can lead to more serious complications, such as pelvic inflammatory disease and infertility. It is important to note that N. gonorrhoeae has developed resistance to many antibiotics over time, making treatment more challenging. A culture or nucleic acid amplification test (NAAT) is used for the diagnosis of this infection.

Imipenem is an antibiotic medication that belongs to the class of carbapenems. It is used to treat various types of bacterial infections, including pneumonia, sepsis, and skin infections. Imipenem works by inhibiting the synthesis of bacterial cell walls, leading to bacterial death.

Imipenem is often combined with another medication called cilastatin, which helps to prevent the breakdown of imipenem in the body and increase its effectiveness. The combination of imipenem and cilastatin is available under the brand name Primaxin.

Like other antibiotics, imipenem should be used with caution and only when necessary, as overuse can lead to antibiotic resistance. It is important to follow the prescribing physician's instructions carefully and complete the full course of treatment, even if symptoms improve before the medication is finished.

Cefsulodin is a type of antibiotic known as a cephalosporin, which is used to treat various bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, which is necessary for its survival. By damaging the cell wall, Cefsulodin causes the bacterium to become unstable and eventually die.

Cefsulodin is a broad-spectrum antibiotic, which means it is effective against a wide range of bacteria. It is often used to treat infections caused by Gram-negative bacteria, such as Pseudomonas aeruginosa, which can be difficult to treat with other types of antibiotics.

Cefsulodin is usually given by injection into a vein (intravenously) or muscle (intramuscularly). It may also be given as a topical solution for skin infections. As with all antibiotics, Cefsulodin should only be used under the direction of a healthcare provider, and it is important to take the full course of treatment as prescribed, even if symptoms improve before the medication is finished.

Like other cephalosporins, Cefsulodin can cause side effects such as diarrhea, nausea, vomiting, and rash. In rare cases, it may also cause serious side effects such as an allergic reaction, kidney damage, or seizures. It is important to inform your healthcare provider of any medical conditions you have and any medications you are taking before starting treatment with Cefsulodin.

Gram-positive bacteria are a type of bacteria that stain dark purple or blue when subjected to the Gram staining method, which is a common technique used in microbiology to classify and identify different types of bacteria based on their structural differences. This staining method was developed by Hans Christian Gram in 1884.

The key characteristic that distinguishes Gram-positive bacteria from other types, such as Gram-negative bacteria, is the presence of a thick layer of peptidoglycan in their cell walls, which retains the crystal violet stain used in the Gram staining process. Additionally, Gram-positive bacteria lack an outer membrane found in Gram-negative bacteria.

Examples of Gram-positive bacteria include Staphylococcus aureus, Streptococcus pyogenes, and Bacillus subtilis. Some Gram-positive bacteria can cause various human diseases, while others are beneficial or harmless.

Gram-negative bacterial infections refer to illnesses or diseases caused by Gram-negative bacteria, which are a group of bacteria that do not retain crystal violet dye during the Gram staining procedure used in microbiology. This characteristic is due to the structure of their cell walls, which contain a thin layer of peptidoglycan and an outer membrane composed of lipopolysaccharides (LPS), proteins, and phospholipids.

The LPS component of the outer membrane is responsible for the endotoxic properties of Gram-negative bacteria, which can lead to severe inflammatory responses in the host. Common Gram-negative bacterial pathogens include Escherichia coli (E. coli), Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Proteus mirabilis, among others.

Gram-negative bacterial infections can cause a wide range of clinical syndromes, such as pneumonia, urinary tract infections, bloodstream infections, meningitis, and soft tissue infections. The severity of these infections can vary from mild to life-threatening, depending on the patient's immune status, the site of infection, and the virulence of the bacterial strain.

Effective antibiotic therapy is crucial for treating Gram-negative bacterial infections, but the increasing prevalence of multidrug-resistant strains has become a significant global health concern. Therefore, accurate diagnosis and appropriate antimicrobial stewardship are essential to ensure optimal patient outcomes and prevent further spread of resistance.

Penicillin-Binding Proteins (PBPs) are essential bacterial enzymes that play a crucial role in the synthesis and maintenance of the bacterial cell wall. They are called "penicillin-binding" because they possess the ability to bind to penicillin and other beta-lactam antibiotics, which subsequently inhibits their function and leads to the death of the bacteria. PBPs are primary targets for many clinically important antibiotics, including penicillins, cephalosporins, and carbapenems. Inhibition of these proteins interferes with the cross-linking of peptidoglycan in the bacterial cell wall, causing structural weakness and osmotic lysis of the bacteria.

Monobactams are a type of antibiotics that contain a single bacterial cell wall-binding component, known as a monocyclic beta-lactam. Aztreonam is an example of a monobactam that is used clinically to treat various infections caused by Gram-negative bacteria, including some strains of Pseudomonas aeruginosa. Monobactams work by inhibiting the enzyme responsible for building the bacterial cell wall, leading to bacterial death. They are not affected by beta-lactamases, which are enzymes produced by some bacteria that can inactivate other types of beta-lactam antibiotics, such as penicillins and cephalosporins.

Escherichia coli (E. coli) infections refer to illnesses caused by the bacterium E. coli, which can cause a range of symptoms depending on the specific strain and site of infection. The majority of E. coli strains are harmless and live in the intestines of healthy humans and animals. However, some strains, particularly those that produce Shiga toxins, can cause severe illness.

E. coli infections can occur through various routes, including contaminated food or water, person-to-person contact, or direct contact with animals or their environments. Common symptoms of E. coli infections include diarrhea (often bloody), abdominal cramps, nausea, and vomiting. In severe cases, complications such as hemolytic uremic syndrome (HUS) can occur, which may lead to kidney failure and other long-term health problems.

Preventing E. coli infections involves practicing good hygiene, cooking meats thoroughly, avoiding cross-contamination of food during preparation, washing fruits and vegetables before eating, and avoiding unpasteurized dairy products and juices. Prompt medical attention is necessary if symptoms of an E. coli infection are suspected to prevent potential complications.

Drug utilization refers to the use of medications by patients or healthcare professionals in a real-world setting. It involves analyzing and evaluating patterns of medication use, including prescribing practices, adherence to treatment guidelines, potential duplications or interactions, and outcomes associated with drug therapy. The goal of drug utilization is to optimize medication use, improve patient safety, and minimize costs while achieving the best possible health outcomes. It can be studied through various methods such as prescription claims data analysis, surveys, and clinical audits.

In the context of medicine, "chemistry" often refers to the field of study concerned with the properties, composition, and structure of elements and compounds, as well as their reactions with one another. It is a fundamental science that underlies much of modern medicine, including pharmacology (the study of drugs), toxicology (the study of poisons), and biochemistry (the study of the chemical processes that occur within living organisms).

In addition to its role as a basic science, chemistry is also used in medical testing and diagnosis. For example, clinical chemistry involves the analysis of bodily fluids such as blood and urine to detect and measure various substances, such as glucose, cholesterol, and electrolytes, that can provide important information about a person's health status.

Overall, chemistry plays a critical role in understanding the mechanisms of diseases, developing new treatments, and improving diagnostic tests and techniques.

Chemical phenomena refer to the changes and interactions that occur at the molecular or atomic level when chemicals are involved. These phenomena can include chemical reactions, in which one or more substances (reactants) are converted into different substances (products), as well as physical properties that change as a result of chemical interactions, such as color, state of matter, and solubility. Chemical phenomena can be studied through various scientific disciplines, including chemistry, biochemistry, and physics.

Citrobacter is a genus of facultatively anaerobic, gram-negative, rod-shaped bacteria that are commonly found in the environment, including water, soil, and the gastrointestinal tracts of animals and humans. Members of this genus are capable of fermenting various sugars and producing acid and gas as end products. Some species of Citrobacter have been associated with human diseases, particularly in individuals with weakened immune systems or underlying medical conditions. Infections caused by Citrobacter can include urinary tract infections, pneumonia, bloodstream infections, and meningitis.

Thienamycins are a group of antibiotics that are characterized by their beta-lactam structure. They belong to the class of carbapenems and are known for their broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria, including many that are resistant to other antibiotics. Thienamycins inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), which leads to bacterial cell death.

Thienamycin itself is not used clinically due to its instability, but several semi-synthetic derivatives of thienamycin have been developed and are used in the treatment of serious infections caused by multidrug-resistant bacteria. Examples of thienamycin derivatives include imipenem, meropenem, and ertapenem. These antibiotics are often reserved for the treatment of severe infections that are unresponsive to other antibiotics due to their potential to select for resistant bacteria and their high cost.

Hydrolysis is a chemical process, not a medical one. However, it is relevant to medicine and biology.

Hydrolysis is the breakdown of a chemical compound due to its reaction with water, often resulting in the formation of two or more simpler compounds. In the context of physiology and medicine, hydrolysis is a crucial process in various biological reactions, such as the digestion of food molecules like proteins, carbohydrates, and fats. Enzymes called hydrolases catalyze these hydrolysis reactions to speed up the breakdown process in the body.

'Proteus' doesn't have a specific medical definition itself, but it is related to a syndrome in medicine. Proteus syndrome is a rare genetic disorder characterized by the overgrowth of various tissues and organs in the body. The name "Proteus" comes from the Greek god Proteus, who could change his form at will, reflecting the diverse and ever-changing nature of this condition's symptoms.

People with Proteus syndrome experience asymmetric overgrowth of bones, skin, and other tissues, leading to abnormalities in body shape and function. The disorder can also affect blood vessels, causing benign tumors called hamartomas to develop. Additionally, individuals with Proteus syndrome are at an increased risk of developing certain types of cancer.

The genetic mutation responsible for Proteus syndrome is found in the AKT1 gene, which plays a crucial role in cell growth and division. This disorder is typically not inherited but instead arises spontaneously as a new mutation in the affected individual. Early diagnosis and management of Proteus syndrome can help improve patients' quality of life and reduce complications associated with the condition.

Proteus vulgaris is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in soil, water, and the human digestive tract. They are named after the Greek god Proteus, who could change his shape at will, as these bacteria are known for their ability to undergo various morphological changes.

Proteus vulgaris is a member of the family Enterobacteriaceae and can cause opportunistic infections in humans, particularly in individuals with weakened immune systems or underlying medical conditions. They can cause a variety of infections, including urinary tract infections, wound infections, pneumonia, and bacteremia (bloodstream infections).

Proteus vulgaris is also known for its ability to produce urease, an enzyme that breaks down urea into ammonia and carbon dioxide. This can lead to the formation of urinary stones and contribute to the development of chronic urinary tract infections. Additionally, Proteus vulgaris can form biofilms, which can make it difficult to eradicate the bacteria from infected sites.

In a medical context, identifying Proteus vulgaris is important for determining appropriate antibiotic therapy and managing infections caused by this organism.

Proteus mirabilis is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, particularly in soil and water. In humans, P. mirabilis can be part of the normal gut flora but can also cause opportunistic infections, particularly in the urinary tract. It is known for its ability to produce urease, which can lead to the formation of urinary stones and blockages.

P. mirabilis infections are often associated with underlying medical conditions such as diabetes, kidney disease, or urinary catheterization. Symptoms of a P. mirabilis infection may include fever, cloudy or foul-smelling urine, and pain or burning during urination. Treatment typically involves antibiotics that are effective against Gram-negative bacteria, although resistance to certain antibiotics is not uncommon in P. mirabilis isolates.

Clavulanic acid is not a medical condition, but rather an antibacterial compound that is often combined with certain antibiotics to increase their effectiveness against bacteria that have become resistant to the antibiotic alone. It works by inhibiting certain enzymes produced by bacteria that help them to resist the antibiotic, allowing the antibiotic to work more effectively.

Clavulanic acid is typically combined with antibiotics such as amoxicillin or ticarcillin to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It is important to note that clavulanate-containing medications should only be used under the direction of a healthcare provider, as misuse or overuse can contribute to antibiotic resistance.

'Citrobacter freundii' is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that is commonly found in the environment, including water, soil, and plants. It is also part of the normal gut flora in humans and animals. The bacterium can cause various types of infections in people with weakened immune systems, such as newborns, the elderly, and those with chronic diseases. Infections caused by 'Citrobacter freundii' may include urinary tract infections, pneumonia, bloodstream infections, and wound infections. Proper identification and antibiotic susceptibility testing are crucial for effective treatment of these infections.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

Penicillin V, also known as Penicillin V Potassium, is an antibiotic medication used to treat various bacterial infections. It belongs to the class of medications called penicillins, which work by interfering with the bacteria's ability to form a protective covering (cell wall), causing the bacteria to become more susceptible to destruction by the body's immune system.

Penicillin V is specifically used to treat infections of the respiratory tract, skin, and ear. It is also used to prevent recurrent rheumatic fever and chorea (Sydenham's chorea), a neurological disorder associated with rheumatic fever.

The medication is available as oral tablets or liquid solutions and is typically taken by mouth every 6 to 12 hours, depending on the severity and type of infection being treated. As with any antibiotic, it is important to take Penicillin V exactly as directed by a healthcare professional and for the full duration of treatment, even if symptoms improve before all doses have been taken.

Penicillin V is generally well-tolerated, but like other penicillins, it can cause allergic reactions in some people. It may also interact with certain medications, so it is important to inform a healthcare provider of any other medications being taken before starting Penicillin V therapy.

Piperacillin is a type of antibiotic known as a semisynthetic penicillin that is used to treat a variety of infections caused by bacteria. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die.

Piperacillin has a broad spectrum of activity against both gram-positive and gram-negative bacteria, including many strains that are resistant to other antibiotics. It is often used in combination with other antibiotics, such as tazobactam, to increase its effectiveness against certain types of bacteria.

Piperacillin is typically administered intravenously in a hospital setting and is used to treat serious infections such as pneumonia, sepsis, and abdominal or urinary tract infections. As with all antibiotics, it should be used only when necessary and under the guidance of a healthcare professional to reduce the risk of antibiotic resistance.

"Providencia" is a term that refers to a type of bacteria that can cause infections in humans. The scientific name for this bacterium is "Providencia stuartii." It is part of the Enterobacteriaceae family and is commonly found in the gastrointestinal tract of humans and animals.

Providencia stuartii can cause a variety of infections, including urinary tract infections, wound infections, and bloodstream infections. It is often resistant to many antibiotics, which can make it difficult to treat. People who are hospitalized, have weakened immune systems, or use catheters are at increased risk for Providencia infections.

It's important to note that while "Providencia" refers to a specific type of bacteria, the term is not typically used in medical diagnoses or treatment. Instead, healthcare providers would specify the type of infection and the name of the bacterium causing it.

Aminoglycosides are a class of antibiotics that are derived from bacteria and are used to treat various types of infections caused by gram-negative and some gram-positive bacteria. These antibiotics work by binding to the 30S subunit of the bacterial ribosome, which inhibits protein synthesis and ultimately leads to bacterial cell death.

Some examples of aminoglycosides include gentamicin, tobramycin, neomycin, and streptomycin. These antibiotics are often used in combination with other antibiotics to treat severe infections, such as sepsis, pneumonia, and urinary tract infections.

Aminoglycosides can have serious side effects, including kidney damage and hearing loss, so they are typically reserved for use in serious infections that cannot be treated with other antibiotics. They are also used topically to treat skin infections and prevent wound infections after surgery.

It's important to note that aminoglycosides should only be used under the supervision of a healthcare professional, as improper use can lead to antibiotic resistance and further health complications.

"Pseudomonas aeruginosa" is a medically important, gram-negative, rod-shaped bacterium that is widely found in the environment, such as in soil, water, and on plants. It's an opportunistic pathogen, meaning it usually doesn't cause infection in healthy individuals but can cause severe and sometimes life-threatening infections in people with weakened immune systems, burns, or chronic lung diseases like cystic fibrosis.

P. aeruginosa is known for its remarkable ability to resist many antibiotics and disinfectants due to its intrinsic resistance mechanisms and the acquisition of additional resistance determinants. It can cause various types of infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, dermatitis, and severe bloodstream infections known as sepsis.

The bacterium produces a variety of virulence factors that contribute to its pathogenicity, such as exotoxins, proteases, and pigments like pyocyanin and pyoverdine, which aid in iron acquisition and help the organism evade host immune responses. Effective infection control measures, appropriate use of antibiotics, and close monitoring of high-risk patients are crucial for managing P. aeruginosa infections.

Bacterial DNA refers to the genetic material found in bacteria. It is composed of a double-stranded helix containing four nucleotide bases - adenine (A), thymine (T), guanine (G), and cytosine (C) - that are linked together by phosphodiester bonds. The sequence of these bases in the DNA molecule carries the genetic information necessary for the growth, development, and reproduction of bacteria.

Bacterial DNA is circular in most bacterial species, although some have linear chromosomes. In addition to the main chromosome, many bacteria also contain small circular pieces of DNA called plasmids that can carry additional genes and provide resistance to antibiotics or other environmental stressors.

Unlike eukaryotic cells, which have their DNA enclosed within a nucleus, bacterial DNA is present in the cytoplasm of the cell, where it is in direct contact with the cell's metabolic machinery. This allows for rapid gene expression and regulation in response to changing environmental conditions.

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

Genetic conjugation is a type of genetic transfer that occurs between bacterial cells. It involves the process of one bacterium (the donor) transferring a piece of its DNA to another bacterium (the recipient) through direct contact or via a bridge-like connection called a pilus. This transferred DNA may contain genes that provide the recipient cell with new traits, such as antibiotic resistance or virulence factors, which can make the bacteria more harmful or difficult to treat. Genetic conjugation is an important mechanism for the spread of antibiotic resistance and other traits among bacterial populations.

Salmonella Paratyphi A is a bacterium that causes a type of enteric fever known as Paratyphoid fever. It's a gram-negative, rod-shaped bacterium that is motile and non-spore forming. This bacterium is transmitted through the fecal-oral route, often through contaminated food or water. The incubation period for paratyphoid fever can range from 5 to 10 days. Symptoms include high fever, headache, abdominal pain, and sometimes a rash. Paratyphoid fever is a systemic infection that can affect various organs in the body, including the liver, spleen, and bone marrow. It's treated with antibiotics, and prevention measures include good hygiene practices, safe food handling, and vaccination for high-risk populations.

Streptococcus pneumoniae, also known as the pneumococcus, is a gram-positive, alpha-hemolytic bacterium frequently found in the upper respiratory tract of healthy individuals. It is a leading cause of community-acquired pneumonia and can also cause other infectious diseases such as otitis media (ear infection), sinusitis, meningitis, and bacteremia (bloodstream infection). The bacteria are encapsulated, and there are over 90 serotypes based on variations in the capsular polysaccharide. Some serotypes are more virulent or invasive than others, and the polysaccharide composition is crucial for vaccine development. S. pneumoniae infection can be treated with antibiotics, but the emergence of drug-resistant strains has become a significant global health concern.

Fluoroquinolones are a class of antibiotics that are widely used to treat various types of bacterial infections. They work by interfering with the bacteria's ability to replicate its DNA, which ultimately leads to the death of the bacterial cells. Fluoroquinolones are known for their broad-spectrum activity against both gram-positive and gram-negative bacteria.

Some common fluoroquinolones include ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin. These antibiotics are often used to treat respiratory infections, urinary tract infections, skin infections, and gastrointestinal infections, among others.

While fluoroquinolones are generally well-tolerated, they can cause serious side effects in some people, including tendonitis, nerve damage, and changes in mood or behavior. As with all antibiotics, it's important to use fluoroquinolones only when necessary and under the guidance of a healthcare provider.

Drug stability refers to the ability of a pharmaceutical drug product to maintain its physical, chemical, and biological properties during storage and use, under specified conditions. A stable drug product retains its desired quality, purity, strength, and performance throughout its shelf life. Factors that can affect drug stability include temperature, humidity, light exposure, and container compatibility. Maintaining drug stability is crucial to ensure the safety and efficacy of medications for patients.

Sulbactam is not a medication itself, but it's a type of β-lactamase inhibitor. It's often combined with other antibiotics such as ampicillin or cefoperazone to increase their effectiveness against bacteria that produce β-lactamases, enzymes that can inactivate certain types of antibiotics (like penicillins and cephalosporins). By inhibiting these enzymes, sulbactam helps to protect the antibiotic from being deactivated, allowing it to maintain its activity against bacteria.

The combination of sulbactam with other antibiotics is used to treat various infections caused by susceptible bacteria, including skin and soft tissue infections, respiratory tract infections, urinary tract infections, and intra-abdominal infections. It's important to note that the specific medical definition of sulbactam would be a β-lactamase inhibitor used in combination with other antibiotics for treating bacterial infections.

Cephapirin is a type of antibiotic that belongs to the class of cephalosporins. It is used to treat various bacterial infections, including respiratory tract infections, skin and soft tissue infections, bone and joint infections, and genitourinary tract infections. Cephapirin works by interfering with the bacteria's ability to form a cell wall, which results in bacterial death.

Like other cephalosporins, cephapirin is generally well-tolerated and has a broad spectrum of activity against many different types of bacteria. However, it may cause side effects such as nausea, diarrhea, vomiting, and allergic reactions in some people. It is important to take cephapirin exactly as directed by a healthcare provider, and to complete the full course of treatment even if symptoms improve before all of the medication has been taken.

It's worth noting that Cephapirin is not a commonly used antibiotic now a days, due to the availability of other cephalosporins which are more effective and have less side effects.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Pulsed-field gel electrophoresis (PFGE) is a type of electrophoresis technique used in molecular biology to separate DNA molecules based on their size and conformation. In this method, the electric field is applied in varying directions, which allows for the separation of large DNA fragments that are difficult to separate using traditional gel electrophoresis methods.

The DNA sample is prepared by embedding it in a semi-solid matrix, such as agarose or polyacrylamide, and then subjected to an electric field that periodically changes direction. This causes the DNA molecules to reorient themselves in response to the changing electric field, which results in the separation of the DNA fragments based on their size and shape.

PFGE is a powerful tool for molecular biology research and has many applications, including the identification and characterization of bacterial pathogens, the analysis of genomic DNA, and the study of gene organization and regulation. It is also used in forensic science to analyze DNA evidence in criminal investigations.

"Sarcina" is not a term that has a specific medical definition in current use. However, in older medical literature or in the context of microbiology, "Sarcina" refers to a genus of Gram-positive, coccoid bacteria that are arranged in tetrads or packets of 4, 8, or 16 cells. These bacteria were once thought to be responsible for a variety of infections, but they are now considered to be rare causes of disease and are not typically tested for in clinical settings.

In modern medical terminology, the term "sarcina" is more commonly used outside of medicine, particularly in the context of physical fitness or exercise, where it refers to a unit of weightlifting or strength training that involves lifting a weight equal to one's own bodyweight.

Muramoylpentapeptide Carboxypeptidase is not a commonly used medical term, but it refers to an enzyme involved in the bacterial cell wall biosynthesis and degradation process. The muramoylpentapeptide is a component of the bacterial cell wall peptidoglycan. Carboxypeptidases are enzymes that cleave peptide bonds, specifically at the carboxyl-terminal end of a protein or peptide.

In this context, Muramoylpentapeptide Carboxypeptidase is an enzyme that removes the terminal D-alanine residue from the muramoylpentapeptide, which is a crucial step in the biosynthesis and recycling of bacterial cell wall components. This enzyme plays a significant role in the regulation of peptidoglycan structure and thus impacts bacterial growth, division, and virulence.

Inhibition or disruption of Muramoylpentapeptide Carboxypeptidase can potentially be used as an antibacterial strategy, targeting essential processes in bacterial cell wall biosynthesis and weakening the structural integrity of pathogenic bacteria.

Salmonella infections, also known as salmonellosis, are a type of foodborne illness caused by the Salmonella bacterium. These bacteria can be found in the intestinal tracts of humans, animals, and birds, especially poultry. People typically get salmonella infections from consuming contaminated foods or water, or through contact with infected animals or their feces. Common sources of Salmonella include raw or undercooked meat, poultry, eggs, and milk products; contaminated fruits and vegetables; and improperly prepared or stored food.

Symptoms of salmonella infections usually begin within 12 to 72 hours after exposure and can include diarrhea, abdominal cramps, fever, nausea, vomiting, and headache. Most people recover from salmonella infections without treatment within four to seven days, although some cases may be severe or even life-threatening, especially in young children, older adults, pregnant women, and people with weakened immune systems. In rare cases, Salmonella can spread from the intestines to the bloodstream and cause serious complications such as meningitis, endocarditis, and arthritis.

Prevention measures include proper food handling, cooking, and storage practices; washing hands thoroughly after using the bathroom, changing diapers, or touching animals; avoiding cross-contamination of foods during preparation; and using pasteurized dairy products and eggs. If you suspect that you have a Salmonella infection, it is important to seek medical attention promptly to prevent complications and reduce the risk of spreading the infection to others.

Staphylococcus aureus is a type of gram-positive, round (coccal) bacterium that is commonly found on the skin and mucous membranes of warm-blooded animals and humans. It is a facultative anaerobe, which means it can grow in the presence or absence of oxygen.

Staphylococcus aureus is known to cause a wide range of infections, from mild skin infections such as pimples, impetigo, and furuncles (boils) to more severe and potentially life-threatening infections such as pneumonia, endocarditis, osteomyelitis, and sepsis. It can also cause food poisoning and toxic shock syndrome.

The bacterium is often resistant to multiple antibiotics, including methicillin, which has led to the emergence of methicillin-resistant Staphylococcus aureus (MRSA) strains that are difficult to treat. Proper hand hygiene and infection control practices are critical in preventing the spread of Staphylococcus aureus and MRSA.

"Plesiomonas" is a genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in aquatic environments. The most well-known species is Plesiomonas shigelloides, which is a potential human pathogen. It can cause gastroenteritis, with symptoms such as diarrhea, abdominal cramps, nausea, and vomiting. The bacteria are often transmitted through the consumption of contaminated food or water. However, it's worth noting that Plesiomonas infections are relatively rare and are more commonly seen in tropical and subtropical regions.

Bacteremia is the presence of bacteria in the bloodstream. It is a medical condition that occurs when bacteria from another source, such as an infection in another part of the body, enter the bloodstream. Bacteremia can cause symptoms such as fever, chills, and rapid heart rate, and it can lead to serious complications such as sepsis if not treated promptly with antibiotics.

Bacteremia is often a result of an infection elsewhere in the body that allows bacteria to enter the bloodstream. This can happen through various routes, such as during medical procedures, intravenous (IV) drug use, or from infected wounds or devices that come into contact with the bloodstream. In some cases, bacteremia may also occur without any obvious source of infection.

It is important to note that not all bacteria in the bloodstream cause harm, and some people may have bacteria in their blood without showing any symptoms. However, if bacteria in the bloodstream multiply and cause an immune response, it can lead to bacteremia and potentially serious complications.

Methicillin is defined as a narrow-spectrum antibiotic that belongs to the penicillin class. It was initially developed to address the problem of beta-lactamase enzyme production in Staphylococcus aureus bacteria, which made them resistant to earlier penicillins. However, methicillin-resistant strains of S. aureus (MRSA) have since emerged and become a significant global health concern. Methicillin is no longer used clinically due to its high nephrotoxicity, but the term "methicillin-resistant" remains relevant in describing resistant bacteria.

Peptidyl transferase is not a medical term per se, but rather a biochemical term used to describe an enzymatic function or activity. It is often mentioned in the context of molecular biology, protein synthesis, and ribosome structure.

Peptidyl transferase refers to the catalytic activity of ribosomes that facilitates the formation of peptide bonds between amino acids during protein synthesis. More specifically, peptidyl transferase is responsible for transferring the peptidyl group (the growing polypeptide chain) from the acceptor site (A-site) to the donor site (P-site) of the ribosome, creating a new peptide bond and elongating the polypeptide chain. This activity occurs within the large subunit of the ribosome, near the peptidyl transferase center (PTC).

While it is often attributed to the ribosomal RNA (rRNA) component of the ribosome, recent research suggests that both rRNA and specific ribosomal proteins contribute to this enzymatic activity.

Anti-infective agents are a class of medications that are used to treat infections caused by various microorganisms such as bacteria, viruses, fungi, and parasites. These agents work by either killing the microorganism or inhibiting its growth, thereby helping to control the infection and alleviate symptoms.

There are several types of anti-infective agents, including:

1. Antibiotics: These are medications that are used to treat bacterial infections. They work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic).
2. Antivirals: These are medications that are used to treat viral infections. They work by interfering with the replication of the virus, preventing it from spreading and causing further damage.
3. Antifungals: These are medications that are used to treat fungal infections. They work by disrupting the cell membrane of the fungus, killing it or inhibiting its growth.
4. Antiparasitics: These are medications that are used to treat parasitic infections. They work by either killing the parasite or inhibiting its growth and reproduction.

It is important to note that anti-infective agents are not effective against all types of infections, and it is essential to use them appropriately to avoid the development of drug-resistant strains of microorganisms.

Spectrophotometry, Infrared is a scientific analytical technique used to measure the absorption or transmission of infrared light by a sample. It involves the use of an infrared spectrophotometer, which directs infrared radiation through a sample and measures the intensity of the radiation that is transmitted or absorbed by the sample at different wavelengths within the infrared region of the electromagnetic spectrum.

Infrared spectroscopy can be used to identify and quantify functional groups and chemical bonds present in a sample, as well as to study the molecular structure and composition of materials. The resulting infrared spectrum provides a unique "fingerprint" of the sample, which can be compared with reference spectra to aid in identification and characterization.

Infrared spectrophotometry is widely used in various fields such as chemistry, biology, pharmaceuticals, forensics, and materials science for qualitative and quantitative analysis of samples.

Kanamycin is an aminoglycoside antibiotic that is derived from the bacterium Streptomyces kanamyceticus. It works by binding to the 30S subunit of the bacterial ribosome, thereby inhibiting protein synthesis and leading to bacterial cell death. Kanamycin is primarily used to treat serious infections caused by Gram-negative bacteria, such as Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae. It is also used in veterinary medicine to prevent bacterial infections in animals.

Like other aminoglycosides, kanamycin can cause ototoxicity (hearing loss) and nephrotoxicity (kidney damage) with prolonged use or high doses. Therefore, it is important to monitor patients closely for signs of toxicity and adjust the dose accordingly. Kanamycin is not commonly used as a first-line antibiotic due to its potential side effects and the availability of safer alternatives. However, it remains an important option for treating multidrug-resistant bacterial infections.

Pseudomembranous enterocolitis is a medical condition characterized by inflammation of the inner lining of the small intestine (enteritis) and large intestine (colitis), resulting in the formation of pseudomembranes – raised, yellowish-white plaques composed of fibrin, mucus, and inflammatory cells. The condition is most commonly caused by a toxin produced by the bacterium Clostridioides difficile (C. difficile), which can overgrow in the gut following disruption of the normal gut microbiota, often after antibiotic use. Symptoms may include diarrhea, abdominal cramps, fever, nausea, and dehydration. Severe cases can lead to complications such as sepsis, toxic megacolon, or even death if left untreated. Treatment typically involves discontinuing the offending antibiotic, administering oral metronidazole or vancomycin to eliminate C. difficile, and managing symptoms with supportive care. In some cases, fecal microbiota transplantation (FMT) may be considered as a treatment option.

Cefonicid is a type of antibiotic known as a cephalosporin, which is used to treat various bacterial infections. It works by interfering with the bacteria's ability to form a cell wall, leading to the death of the bacteria. Cefonicid is administered intravenously and is typically used to treat serious infections such as sepsis, pneumonia, and meningitis.

Here is the medical definition of 'Cefonicid':

Cefonicid is a semisynthetic, broad-spectrum, bactericidal antibiotic of the cephalosporin class. It is administered intravenously and has a long half-life, allowing for once- or twice-daily dosing. Cefonicid is stable in the presence of beta-lactamases, including extended-spectrum beta-lactamases (ESBLs), making it useful for treating infections caused by bacteria that produce these enzymes. It is used to treat a variety of bacterial infections, including pneumonia, meningitis, and sepsis.

Common side effects of cefonicid include diarrhea, nausea, vomiting, and local reactions at the injection site. More serious side effects can include allergic reactions, kidney damage, and seizures. Cefonicid should be used with caution in patients with a history of allergy to beta-lactam antibiotics, impaired renal function, or a history of seizure disorders.

Culture media is a substance that is used to support the growth of microorganisms or cells in an artificial environment, such as a petri dish or test tube. It typically contains nutrients and other factors that are necessary for the growth and survival of the organisms being cultured. There are many different types of culture media, each with its own specific formulation and intended use. Some common examples include blood agar, which is used to culture bacteria; Sabouraud dextrose agar, which is used to culture fungi; and Eagle's minimum essential medium, which is used to culture animal cells.

Enterococcus is a genus of gram-positive, facultatively anaerobic bacteria that are commonly found in the intestinal tracts of humans and animals. They are part of the normal gut microbiota but can also cause a variety of infections, particularly in hospital settings. Enterococci are known for their ability to survive in harsh environments and can be resistant to many antibiotics, making them difficult to treat. Some species, such as Enterococcus faecalis and Enterococcus faecium, are more commonly associated with human infections.

In medical terms, an "Enterococcus infection" refers to an infection caused by any species of the Enterococcus genus. These infections can occur in various parts of the body, including the urinary tract, bloodstream, and abdominal cavity. They can cause symptoms such as fever, chills, and pain, depending on the location of the infection. Treatment typically involves the use of antibiotics that are effective against Enterococcus species, although resistance to multiple antibiotics is a growing concern.

A Serine-type D-Ala-D-Ala Carboxypeptidase is a type of enzyme that specifically catalyzes the cleavage of the peptide bond at the carboxyl terminus of a polypeptide, where the penultimate residue is D-alanine and the ultimate residue is D-alanine. This enzyme plays an essential role in bacterial cell wall biosynthesis and is a crucial target for antibiotics such as vancomycin and teicoplanin, which inhibit its activity by binding to the D-Ala-D-Ala motif of the peptidoglycan precursor. The serine residue in the active site of this enzyme is involved in the catalytic mechanism, hence the name "serine-type" carboxypeptidase.

A hospital is a healthcare facility where patients receive medical treatment, diagnosis, and care for various health conditions, injuries, or diseases. It is typically staffed with medical professionals such as doctors, nurses, and other healthcare workers who provide round-the-clock medical services. Hospitals may offer inpatient (overnight) stays or outpatient (same-day) services, depending on the nature of the treatment required. They are equipped with various medical facilities like operating rooms, diagnostic equipment, intensive care units (ICUs), and emergency departments to handle a wide range of medical situations. Hospitals may specialize in specific areas of medicine, such as pediatrics, geriatrics, oncology, or trauma care.

'Bacteroides fragilis' is a species of gram-negative, anaerobic, rod-shaped bacteria that are commonly found in the human gastrointestinal tract. They are part of the normal gut flora and play an important role in maintaining a healthy digestive system. However, they can also cause infections when they enter other parts of the body, such as the abdomen or bloodstream, particularly in individuals with weakened immune systems.

Bacteroides fragilis is known for its ability to produce enzymes that allow it to resist antibiotics and evade the host's immune system. This makes it a challenging bacterium to treat and can lead to serious and potentially life-threatening infections, such as abscesses, sepsis, and meningitis.

Proper hygiene, such as handwashing and safe food handling practices, can help prevent the spread of Bacteroides fragilis and other bacteria that can cause infections. If an infection does occur, it is typically treated with a combination of surgical drainage and antibiotics that are effective against anaerobic bacteria.

Gram-negative aerobic bacteria are a type of bacteria that do not retain the crystal violet stain used in the Gram staining method, which is a technique used to differentiate bacterial species based on their cell wall composition. These bacteria have a thin peptidoglycan layer and an outer membrane containing lipopolysaccharides (LPS), making them resistant to many antibiotics and disinfectants. They are called aerobic because they require oxygen for their growth and metabolism. Examples of Gram-negative aerobic bacteria include Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. These bacteria can cause various infections in humans, such as pneumonia, urinary tract infections, and sepsis.

"Salmonella enterica" is a gram-negative, facultatively anaerobic bacterium that belongs to the family Enterobacteriaceae. It is a common cause of foodborne illnesses worldwide, often resulting in gastroenteritis, which is characterized by symptoms such as diarrhea, abdominal cramps, fever, and vomiting.

"Salmonella enterica" is further divided into several serovars or subspecies, with some of the most common ones causing human illness being Typhimurium and Enteritidis. These bacteria are typically transmitted to humans through contaminated food or water sources, such as raw or undercooked meat, poultry, eggs, and dairy products.

Once ingested, "Salmonella enterica" can colonize the gastrointestinal tract and release endotoxins that cause inflammation and damage to the intestinal lining. In some cases, the bacteria can spread to other parts of the body, leading to more severe and potentially life-threatening infections, particularly in individuals with weakened immune systems.

Preventing "Salmonella enterica" infections involves proper food handling and preparation practices, such as washing hands and surfaces thoroughly, cooking meats and eggs to appropriate temperatures, and avoiding cross-contamination between raw and cooked foods.

Oral administration is a route of giving medications or other substances by mouth. This can be in the form of tablets, capsules, liquids, pastes, or other forms that can be swallowed. Once ingested, the substance is absorbed through the gastrointestinal tract and enters the bloodstream to reach its intended target site in the body. Oral administration is a common and convenient route of medication delivery, but it may not be appropriate for all substances or in certain situations, such as when rapid onset of action is required or when the patient has difficulty swallowing.

The Amoxicillin-Potassium Clavulanate Combination is an antibiotic medication used to treat various infections caused by bacteria. This combination therapy combines the antibiotic amoxicillin with potassium clavulanate, which is a beta-lactamase inhibitor. The addition of potassium clavulanate helps protect amoxicillin from being broken down by certain types of bacteria that produce beta-lactamases, thus increasing the effectiveness of the antibiotic against a broader range of bacterial infections.

Amoxicillin is a type of penicillin antibiotic that works by inhibiting the synthesis of the bacterial cell wall, ultimately leading to bacterial death. However, some bacteria have developed enzymes called beta-lactamases, which can break down and inactivate certain antibiotics like amoxicillin. Potassium clavulanate is added to the combination to inhibit these beta-lactamase enzymes, allowing amoxicillin to maintain its effectiveness against a wider range of bacteria.

This combination medication is used to treat various infections, including skin and soft tissue infections, respiratory tract infections, urinary tract infections, and dental infections. It's essential to follow the prescribed dosage and duration as directed by a healthcare professional to ensure effective treatment and prevent antibiotic resistance.

Common brand names for this combination include Augmentin and Amoxiclav.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Staphylococcus is a genus of Gram-positive, facultatively anaerobic bacteria that are commonly found on the skin and mucous membranes of humans and other animals. Many species of Staphylococcus can cause infections in humans, but the most notable is Staphylococcus aureus, which is responsible for a wide range of illnesses, from minor skin infections to life-threatening conditions such as pneumonia, endocarditis, and sepsis.

Staphylococcus species are non-motile, non-spore forming, and typically occur in grape-like clusters when viewed under a microscope. They can be coagulase-positive or coagulase-negative, with S. aureus being the most well-known coagulase-positive species. Coagulase is an enzyme that causes the clotting of plasma, and its presence is often used to differentiate S. aureus from other Staphylococcus species.

These bacteria are resistant to many commonly used antibiotics, including penicillin, due to the production of beta-lactamases. Methicillin-resistant Staphylococcus aureus (MRSA) is a particularly problematic strain that has developed resistance to multiple antibiotics and can cause severe, difficult-to-treat infections.

Proper hand hygiene, use of personal protective equipment, and environmental cleaning are crucial measures for preventing the spread of Staphylococcus in healthcare settings and the community.

"Enterobacter aerogenes" is a species of gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, including in soil, water, and vegetation. In medical contexts, E. aerogenes is often considered an opportunistic pathogen, meaning it can cause infection in individuals with compromised immune systems or underlying health conditions.

E. aerogenes is a member of the family Enterobacteriaceae and is closely related to other pathogens such as Klebsiella pneumoniae and Escherichia coli. It is known for its ability to produce large amounts of gas, including carbon dioxide and hydrogen sulfide, which can contribute to its virulence and make it difficult to identify using traditional biochemical tests.

E. aerogenes can cause a variety of infections, including urinary tract infections, pneumonia, bacteremia, and wound infections. It is often resistant to multiple antibiotics, which can make treatment challenging. In recent years, there has been an increase in the number of E. aerogenes isolates that are resistant to carbapenems, a class of antibiotics that are often used as a last resort for treating serious bacterial infections.

Aminohippuric acids are a type of organic compound that contain both an amino group and a hippuric acid group in their chemical structure. Hippuric acid is a derivative of benzoic acid, which is conjugated with glycine in the body. Aminohippuric acids are primarily known for their use as diagnostic agents in renal function tests.

The most common aminohippuric acid is p-aminohippuric acid (PAH), which is used as a marker to measure effective renal plasma flow (ERPF) in the kidneys. PAH is freely filtered by the glomeruli and then actively secreted by the proximal tubules of the nephrons, making it an ideal agent for measuring ERPF.

In a renal function test using PAH, a small dose of the compound is injected into the patient's bloodstream, and its concentration in the blood is measured over time. By analyzing the clearance rate of PAH from the blood, healthcare providers can estimate the ERPF and assess kidney function.

Overall, aminohippuric acids are important diagnostic tools for evaluating renal function and identifying potential kidney-related health issues.

'Acinetobacter baumannii' is a gram-negative, aerobic, coccobacillus-shaped bacterium that is commonly found in the environment, including water, soil, and healthcare settings. It is known to cause various types of infections in humans, particularly in hospitalized patients or those with weakened immune systems.

This bacterium can cause a range of infections, such as pneumonia, bloodstream infections, meningitis, and wound infections. 'Acinetobacter baumannii' is often resistant to multiple antibiotics, making it difficult to treat the resulting infections. This has led to its classification as a "superbug" or a multidrug-resistant organism (MDRO).

The medical community continues to research and develop new strategies to prevent and treat infections caused by 'Acinetobacter baumannii' and other antibiotic-resistant bacteria.

Penicillin amidase is not a medical term per se, but rather a biochemical term. It's also known as penicillin acylase or simply penicillinase. It refers to an enzyme that can break down certain types of penicillin antibiotics by cleaving the amide bond in the beta-lactam ring, which is the core structure of these antibiotics. This makes the antibiotic ineffective.

Beta-lactam antibiotics include penicillins and cephalosporins, among others. Some bacteria produce penicillin amidases as a form of resistance to these antibiotics. The enzyme can be used in biotechnology to produce semi-synthetic penicillins by cleaving the side chain of a parent penicillin and then attaching a different side chain, creating a new antibiotic with potentially different properties.

'Eikenella corrodens' is a gram-negative, rod-shaped, facultatively anaerobic bacterium that is commonly found as normal flora in the human oral cavity, upper respiratory tract, and gastrointestinal tract. It is named for its ability to corrode or pit the surface of culture media.

Eikenella corrodens is a opportunistic pathogen that can cause localized infections such as abscesses, cellulitis, and endocarditis, particularly in individuals with underlying medical conditions or compromised immune systems. It has also been associated with bite wounds, human and animal bites, and trauma to the head and neck.

Eikenella corrodens is often resistant to beta-lactam antibiotics such as penicillin and ampicillin due to the production of beta-lactamase enzyme. However, it remains susceptible to other antibiotics such as carbapenems, cephalosporins, fluoroquinolones, and tetracyclines.

Medical treatment for Eikenella corrodens infections typically involves the use of appropriate antibiotics based on antimicrobial susceptibility testing, along with surgical debridement or drainage of any abscesses or collections of pus.

Hexosyltransferases are a group of enzymes that catalyze the transfer of a hexose (a type of sugar molecule made up of six carbon atoms) from a donor molecule to an acceptor molecule. This transfer results in the formation of a glycosidic bond between the two molecules.

Hexosyltransferases are involved in various biological processes, including the biosynthesis of complex carbohydrates, such as glycoproteins and glycolipids, which play important roles in cell recognition, signaling, and communication. These enzymes can transfer a variety of hexose sugars, including glucose, galactose, mannose, fucose, and N-acetylglucosamine, to different acceptor molecules, such as proteins, lipids, or other carbohydrates.

Hexosyltransferases are classified based on the type of donor molecule they use, the type of sugar they transfer, and the type of glycosidic bond they form. Some examples of hexosyltransferases include:

* Glycosyltransferases (GTs): These enzymes transfer a sugar from an activated donor molecule, such as a nucleotide sugar, to an acceptor molecule. GTs are involved in the biosynthesis of various glycoconjugates, including proteoglycans, glycoproteins, and glycolipids.
* Fucosyltransferases (FUTs): These enzymes transfer fucose, a type of hexose sugar, to an acceptor molecule. FUTs are involved in the biosynthesis of various glycoconjugates, including blood group antigens and Lewis antigens.
* Galactosyltransferases (GALTs): These enzymes transfer galactose, another type of hexose sugar, to an acceptor molecule. GALTs are involved in the biosynthesis of various glycoconjugates, including lactose in milk and gangliosides in the brain.
* Mannosyltransferases (MTs): These enzymes transfer mannose, a type of hexose sugar, to an acceptor molecule. MTs are involved in the biosynthesis of various glycoconjugates, including N-linked glycoproteins and yeast cell walls.

Hexosyltransferases play important roles in many biological processes, including cell recognition, signaling, and adhesion. Dysregulation of these enzymes has been implicated in various diseases, such as cancer, inflammation, and neurodegenerative disorders. Therefore, understanding the mechanisms of hexosyltransferases is crucial for developing new therapeutic strategies.

'Acinetobacter' is a genus of gram-negative, aerobic bacteria that are commonly found in the environment, including water, soil, and healthcare settings. They are known for their ability to survive in a wide range of temperatures and pH levels, as well as their resistance to many antibiotics.

Some species of Acinetobacter can cause healthcare-associated infections, particularly in patients who are hospitalized, have weakened immune systems, or have been exposed to medical devices such as ventilators or catheters. These infections can include pneumonia, bloodstream infections, wound infections, and meningitis.

Acinetobacter baumannii is one of the most common species associated with human infection and is often resistant to multiple antibiotics, making it a significant public health concern. Infections caused by Acinetobacter can be difficult to treat and may require the use of last-resort antibiotics.

Preventing the spread of Acinetobacter in healthcare settings is important and includes practices such as hand hygiene, environmental cleaning, and contact precautions for patients with known or suspected infection.

Paratyphoid fever is an acute infectious disease, similar to typhoid fever, caused by the Salmonella enterica serotype Paratyphi bacteria. The illness is characterized by fever, headache, abdominal pain, and occasionally rash. It's spread through contaminated food and water, and it primarily affects the intestinal tract and sometimes the bloodstream. Symptoms typically appear within a week of exposure and may include sustained fever, malaise, muscle aches, headache, cough, and constipation or diarrhea. Paratyphoid fever can be prevented by practicing good sanitation and hygiene, such as frequent hand washing, and is treated with antibiotics.

Bacteroides are a genus of gram-negative, anaerobic, rod-shaped bacteria that are normally present in the human gastrointestinal tract. They are part of the normal gut microbiota and play an important role in breaking down complex carbohydrates and other substances in the gut. However, some species of Bacteroides can cause opportunistic infections, particularly in individuals with weakened immune systems or when they spread to other parts of the body. They are resistant to many commonly used antibiotics, making infections caused by these bacteria difficult to treat.

'Clostridium difficile' (also known as 'C. difficile' or 'C. diff') is a type of Gram-positive, spore-forming bacterium that can be found in the environment, including in soil, water, and human and animal feces. It is a common cause of healthcare-associated infections, particularly in individuals who have recently received antibiotics or have other underlying health conditions that weaken their immune system.

C. difficile produces toxins that can cause a range of symptoms, from mild diarrhea to severe colitis (inflammation of the colon) and potentially life-threatening complications such as sepsis and toxic megacolon. The most common toxins produced by C. difficile are called TcdA and TcdB, which damage the lining of the intestine and cause inflammation.

C. difficile infections (CDIs) can be difficult to treat, particularly in severe cases or in patients who have recurrent infections. Treatment typically involves discontinuing any unnecessary antibiotics, if possible, and administering specific antibiotics that are effective against C. difficile, such as metronidazole, vancomycin, or fidaxomicin. In some cases, fecal microbiota transplantation (FMT) may be recommended as a last resort for patients with recurrent or severe CDIs who have not responded to other treatments.

Preventing the spread of C. difficile is critical in healthcare settings, and includes measures such as hand hygiene, contact precautions, environmental cleaning, and antibiotic stewardship programs that promote the appropriate use of antibiotics.

Salmonella typhi is a bacterium that causes typhoid fever, a severe and sometimes fatal infectious disease. It is a human-specific pathogen, which means it only infects humans and is not carried in animals or birds. The bacteria are spread through the fecal-oral route, often through contaminated food or water. Once ingested, Salmonella typhi can invade the intestinal tract, causing symptoms such as high fever, headache, abdominal pain, constipation, and rose-colored spots on the chest. If left untreated, typhoid fever can lead to serious complications, including intestinal perforation, bacteremia, and death.

I'm sorry for any confusion, but "Sulbenicillin" is not a recognized or established term in medical science or pharmacology. It seems that there might be a spelling mistake or a mix-up with the names of antibiotics. If you meant "Subenicillin," it also doesn't exist in medical literature as a known drug.

If you have any other questions about medical definitions, please provide the correct term, and I will be happy to help.

Salmonella is a genus of rod-shaped, Gram-negative bacteria that are facultative anaerobes and are motile due to peritrichous flagella. They are non-spore forming and often have a single polar flagellum when grown in certain conditions. Salmonella species are important pathogens in humans and other animals, causing foodborne illnesses known as salmonellosis.

Salmonella can be found in the intestinal tracts of humans, birds, reptiles, and mammals. They can contaminate various foods, including meat, poultry, eggs, dairy products, and fresh produce. The bacteria can survive and multiply in a wide range of temperatures and environments, making them challenging to control completely.

Salmonella infection typically leads to gastroenteritis, characterized by symptoms such as diarrhea, abdominal cramps, fever, and vomiting. In some cases, the infection may spread beyond the intestines, leading to more severe complications like bacteremia (bacterial infection of the blood) or focal infections in various organs.

There are two main species of Salmonella: S. enterica and S. bongori. S. enterica is further divided into six subspecies and numerous serovars, with over 2,500 distinct serotypes identified to date. Some well-known Salmonella serovars include S. Typhi (causes typhoid fever), S. Paratyphi A, B, and C (cause paratyphoid fever), and S. Enteritidis and S. Typhimurium (common causes of foodborne salmonellosis).

Drug hypersensitivity is an abnormal immune response to a medication or its metabolites. It is a type of adverse drug reaction that occurs in susceptible individuals, characterized by the activation of the immune system leading to inflammation and tissue damage. This reaction can range from mild symptoms such as skin rashes, hives, and itching to more severe reactions like anaphylaxis, which can be life-threatening.

Drug hypersensitivity reactions can be classified into two main types: immediate (or IgE-mediated) and delayed (or non-IgE-mediated). Immediate reactions occur within minutes to a few hours after taking the medication and are mediated by the release of histamine and other inflammatory mediators from mast cells and basophils. Delayed reactions, on the other hand, can take several days to develop and are caused by T-cell activation and subsequent cytokine release.

Common drugs that can cause hypersensitivity reactions include antibiotics (such as penicillins and sulfonamides), nonsteroidal anti-inflammatory drugs (NSAIDs), monoclonal antibodies, and chemotherapeutic agents. It is important to note that previous exposure to a medication does not always guarantee the development of hypersensitivity reactions, as they can also occur after the first administration in some cases.

The diagnosis of drug hypersensitivity involves a thorough medical history, physical examination, and sometimes skin or laboratory tests. Treatment typically includes avoiding the offending medication and managing symptoms with antihistamines, corticosteroids, or other medications as needed. In severe cases, emergency medical care may be required to treat anaphylaxis or other life-threatening reactions.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form a cell wall, which is necessary for their survival. This causes the bacterial cells to become unstable and eventually die. Carbenicillin is effective against a wide range of gram-negative bacteria, including Pseudomonas aeruginosa, and is often used to treat serious infections caused by these organisms. It is administered orally or intravenously, depending on the type and severity of the infection being treated.

Carbenicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to

Drug synergism is a pharmacological concept that refers to the interaction between two or more drugs, where the combined effect of the drugs is greater than the sum of their individual effects. This means that when these drugs are administered together, they produce an enhanced therapeutic response compared to when they are given separately.

Drug synergism can occur through various mechanisms, such as:

1. Pharmacodynamic synergism - When two or more drugs interact with the same target site in the body and enhance each other's effects.
2. Pharmacokinetic synergism - When one drug affects the metabolism, absorption, distribution, or excretion of another drug, leading to an increased concentration of the second drug in the body and enhanced therapeutic effect.
3. Physiochemical synergism - When two drugs interact physically, such as when one drug enhances the solubility or permeability of another drug, leading to improved absorption and bioavailability.

It is important to note that while drug synergism can result in enhanced therapeutic effects, it can also increase the risk of adverse reactions and toxicity. Therefore, healthcare providers must carefully consider the potential benefits and risks when prescribing combinations of drugs with known or potential synergistic effects.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

Ampicillin resistance is a type of antibiotic resistance where bacteria have the ability to grow in the presence of ampicillin, a beta-lactam antibiotic used to treat various infections. This resistance occurs due to the production of enzymes called beta-lactamases that can break down the ampicillin molecule, rendering it ineffective. Additionally, some bacteria may have mutations that result in changes to their cell wall structure, making them impervious to the effects of ampicillin. Ampicillin resistance is a significant public health concern as it limits treatment options for infections caused by these resistant bacteria and can lead to increased morbidity and mortality.

"Multiple drug resistance" (MDR) is a term used in medicine to describe the condition where a patient's infection becomes resistant to multiple antimicrobial drugs. This means that the bacteria, virus, fungus or parasite that is causing the infection has developed the ability to survive and multiply despite being exposed to medications that were originally designed to kill or inhibit its growth.

In particular, MDR occurs when an organism becomes resistant to at least one drug in three or more antimicrobial categories. This can happen due to genetic changes in the microorganism that allow it to survive in the presence of these drugs. The development of MDR is a significant concern for public health because it limits treatment options and can make infections harder, if not impossible, to treat.

MDR can develop through several mechanisms, including mutations in the genes that encode drug targets or enzymes involved in drug metabolism, as well as the acquisition of genetic elements such as plasmids and transposons that carry resistance genes. The overuse and misuse of antimicrobial drugs are major drivers of MDR, as they create selective pressure for the emergence and spread of resistant strains.

MDR infections can occur in various settings, including hospitals, long-term care facilities, and communities. They can affect people of all ages and backgrounds, although certain populations may be at higher risk, such as those with weakened immune systems or chronic medical conditions. Preventing the spread of MDR requires a multifaceted approach that includes surveillance, infection control, antimicrobial stewardship, and research into new therapies and diagnostics.

Haemophilus influenzae is a gram-negative, coccobacillary bacterium that can cause a variety of infectious diseases in humans. It is part of the normal respiratory flora but can become pathogenic under certain circumstances. The bacteria are named after their initial discovery in 1892 by Richard Pfeiffer during an influenza pandemic, although they are not the causative agent of influenza.

There are six main serotypes (a-f) based on the polysaccharide capsule surrounding the bacterium, with type b (Hib) being the most virulent and invasive. Hib can cause severe invasive diseases such as meningitis, pneumonia, epiglottitis, and sepsis, particularly in children under 5 years of age. The introduction of the Hib conjugate vaccine has significantly reduced the incidence of these invasive diseases.

Non-typeable Haemophilus influenzae (NTHi) strains lack a capsule and are responsible for non-invasive respiratory tract infections, such as otitis media, sinusitis, and exacerbations of chronic obstructive pulmonary disease (COPD). NTHi can also cause invasive diseases but at lower frequency compared to Hib.

Proper diagnosis and antibiotic susceptibility testing are crucial for effective treatment, as Haemophilus influenzae strains may display resistance to certain antibiotics.

Porins are a type of protein found in the outer membrane of gram-negative bacteria. They form water-filled channels, or pores, that allow small molecules such as ions, nutrients, and waste products to pass through the otherwise impermeable outer membrane. Porins are important for the survival of gram-negative bacteria, as they enable the selective transport of essential molecules while providing a barrier against harmful substances.

There are different types of porins, classified based on their structure and function. Some examples include:

1. General porins (also known as nonspecific porins): These are the most common type of porins and form large, water-filled channels that allow passive diffusion of small molecules up to 600-700 Da in size. They typically have a trimeric structure, with three identical or similar subunits forming a pore in the membrane.
2. Specific porins: These porins are more selective in the molecules they allow to pass through and often have smaller pores than general porins. They can be involved in the active transport of specific molecules or ions, requiring energy from the cell.
3. Autotransporters: While not strictly considered porins, autotransporter proteins share some structural similarities with porins and are involved in the transport of protein domains across the outer membrane. They consist of an N-terminal passenger domain and a C-terminal translocator domain, which forms a β-barrel pore in the outer membrane through which the passenger domain is transported.

Porins have attracted interest as potential targets for antibiotic development, as they play crucial roles in bacterial survival and virulence. Inhibiting porin function or blocking the pores could disrupt essential processes in gram-negative bacteria, providing a new approach to treating infections caused by these organisms.

Bacterial meningitis is a serious infection that causes the membranes (meninges) surrounding the brain and spinal cord to become inflamed. It's caused by various types of bacteria, such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type b.

The infection can develop quickly, over a few hours or days, and is considered a medical emergency. Symptoms may include sudden high fever, severe headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light. In some cases, a rash may also be present.

Bacterial meningitis can lead to serious complications such as brain damage, hearing loss, learning disabilities, and even death if not treated promptly with appropriate antibiotics and supportive care. It is important to seek immediate medical attention if you suspect bacterial meningitis. Vaccines are available to prevent certain types of bacterial meningitis.

Pseudomonas infections are infections caused by the bacterium Pseudomonas aeruginosa or other species of the Pseudomonas genus. These bacteria are gram-negative, opportunistic pathogens that can cause various types of infections, including respiratory, urinary tract, gastrointestinal, dermatological, and bloodstream infections.

Pseudomonas aeruginosa is a common cause of healthcare-associated infections, particularly in patients with weakened immune systems, chronic lung diseases, or those who are hospitalized for extended periods. The bacteria can also infect wounds, burns, and medical devices such as catheters and ventilators.

Pseudomonas infections can be difficult to treat due to the bacteria's resistance to many antibiotics. Treatment typically involves the use of multiple antibiotics that are effective against Pseudomonas aeruginosa. In severe cases, intravenous antibiotics or even hospitalization may be necessary.

Prevention measures include good hand hygiene, contact precautions for patients with known Pseudomonas infections, and proper cleaning and maintenance of medical equipment.

"Nocardia asteroides" is a species of aerobic, gram-positive bacteria that can be found in soil and water. It is a type of actinomycete that can cause various infectious diseases in humans and animals, known as nocardiosis. The bacterium has the ability to form branching filaments, which can resemble fungal hyphae, and it often forms hard, rough colonies on culture media. Nocardia asteroides is known for its resistance to various antibiotics and can cause a range of clinical manifestations, including pulmonary, cutaneous, and disseminated infections. It is typically treated with drugs such as sulfonamides, trimethoprim-sulfamethoxazole, or imipenem.

Quinolones are a class of antibacterial agents that are widely used in medicine to treat various types of infections caused by susceptible bacteria. These synthetic drugs contain a chemical structure related to quinoline and have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Quinolones work by inhibiting the bacterial DNA gyrase or topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, and repair.

The first quinolone antibiotic was nalidixic acid, discovered in 1962. Since then, several generations of quinolones have been developed, with each generation having improved antibacterial activity and a broader spectrum of action compared to the previous one. The various generations of quinolones include:

1. First-generation quinolones (e.g., nalidixic acid): Primarily used for treating urinary tract infections caused by Gram-negative bacteria.
2. Second-generation quinolones (e.g., ciprofloxacin, ofloxacin, norfloxacin): These drugs have improved activity against both Gram-positive and Gram-negative bacteria and are used to treat a wider range of infections, including respiratory, gastrointestinal, and skin infections.
3. Third-generation quinolones (e.g., levofloxacin, sparfloxacin, grepafloxacin): These drugs have enhanced activity against Gram-positive bacteria, including some anaerobes and atypical organisms like Legionella and Mycoplasma species.
4. Fourth-generation quinolones (e.g., moxifloxacin, gatifloxacin): These drugs have the broadest spectrum of activity, including enhanced activity against Gram-positive bacteria, anaerobes, and some methicillin-resistant Staphylococcus aureus (MRSA) strains.

Quinolones are generally well-tolerated, but like all medications, they can have side effects. Common adverse reactions include gastrointestinal symptoms (nausea, vomiting, diarrhea), headache, and dizziness. Serious side effects, such as tendinitis, tendon rupture, peripheral neuropathy, and QT interval prolongation, are less common but can occur, particularly in older patients or those with underlying medical conditions. The use of quinolones should be avoided or used cautiously in these populations.

Quinolone resistance has become an increasing concern due to the widespread use of these antibiotics. Bacteria can develop resistance through various mechanisms, including chromosomal mutations and the acquisition of plasmid-mediated quinolone resistance genes. The overuse and misuse of quinolones contribute to the emergence and spread of resistant strains, which can limit treatment options for severe infections caused by these bacteria. Therefore, it is essential to use quinolones judiciously and only when clinically indicated, to help preserve their effectiveness and prevent further resistance development.

"Serratia marcescens" is a medically significant species of gram-negative, facultatively anaerobic, motile bacillus bacteria that belongs to the family Enterobacteriaceae. It is commonly found in soil, water, and in the gastrointestinal tracts of humans and animals. The bacteria are known for their ability to produce a red pigment called prodigiosin, which gives them a distinctive pink color on many types of laboratory media.

"Serratia marcescens" can cause various types of infections, including respiratory tract infections, urinary tract infections, wound infections, and bacteremia (bloodstream infections). It is also known to be an opportunistic pathogen, which means that it primarily causes infections in individuals with weakened immune systems, such as those with chronic illnesses or who are undergoing medical treatments that suppress the immune system.

In healthcare settings, "Serratia marcescens" can cause outbreaks of infection, particularly in patients who are hospitalized for extended periods of time. It is resistant to many commonly used antibiotics, which makes it difficult to treat and control the spread of infections caused by this organism.

In addition to its medical significance, "Serratia marcescens" has also been used as a model organism in various areas of microbiological research, including studies on bacterial motility, biofilm formation, and antibiotic resistance.

Vancomycin is an antibiotic that belongs to the glycopeptide class. It is primarily used to treat severe infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Vancomycin works by inhibiting the synthesis of bacterial cell walls. It is usually administered intravenously in a hospital setting due to its potential nephrotoxicity and ototoxicity. The medical definition of 'Vancomycin' can be summarized as:

"A glycopeptide antibiotic used to treat severe infections caused by Gram-positive bacteria, particularly those that are resistant to other antibiotics. It inhibits bacterial cell wall synthesis and is administered intravenously due to its potential nephrotoxicity and ototoxicity."

ICR (Institute of Cancer Research) is a strain of albino Swiss mice that are widely used in scientific research. They are an outbred strain, which means that they have been bred to maintain maximum genetic heterogeneity. However, it is also possible to find inbred strains of ICR mice, which are genetically identical individuals produced by many generations of brother-sister mating.

Inbred ICR mice are a specific type of ICR mouse that has been inbred for at least 20 generations. This means that they have a high degree of genetic uniformity and are essentially genetically identical to one another. Inbred strains of mice are often used in research because their genetic consistency makes them more reliable models for studying biological phenomena and testing new therapies or treatments.

It is important to note that while inbred ICR mice may be useful for certain types of research, they do not necessarily represent the genetic diversity found in human populations. Therefore, it is important to consider the limitations of using any animal model when interpreting research findings and applying them to human health.

Urinary Tract Infections (UTIs) are defined as the presence of pathogenic microorganisms, typically bacteria, in any part of the urinary system, which includes the kidneys, ureters, bladder, and urethra, resulting in infection and inflammation. The majority of UTIs are caused by Escherichia coli (E. coli) bacteria, but other organisms such as Klebsiella, Proteus, Staphylococcus saprophyticus, and Enterococcus can also cause UTIs.

UTIs can be classified into two types based on the location of the infection:

1. Lower UTI or bladder infection (cystitis): This type of UTI affects the bladder and urethra. Symptoms may include a frequent and urgent need to urinate, pain or burning during urination, cloudy or strong-smelling urine, and discomfort in the lower abdomen or back.

2. Upper UTI or kidney infection (pyelonephritis): This type of UTI affects the kidneys and can be more severe than a bladder infection. Symptoms may include fever, chills, nausea, vomiting, and pain in the flanks or back.

UTIs are more common in women than men due to their shorter urethra, which makes it easier for bacteria to reach the bladder. Other risk factors for UTIs include sexual activity, use of diaphragms or spermicides, urinary catheterization, diabetes, and weakened immune systems.

UTIs are typically diagnosed through a urinalysis and urine culture to identify the causative organism and determine the appropriate antibiotic treatment. In some cases, imaging studies such as ultrasound or CT scan may be necessary to evaluate for any underlying abnormalities in the urinary tract.

Amidohydrolases are a class of enzymes that catalyze the hydrolysis of amides and related compounds, resulting in the formation of an acid and an alcohol. This reaction is also known as amide hydrolysis or amide bond cleavage. Amidohydrolases play important roles in various biological processes, including the metabolism of xenobiotics (foreign substances) and endogenous compounds (those naturally produced within an organism).

The term "amidohydrolase" is a broad one that encompasses several specific types of enzymes, such as proteases, esterases, lipases, and nitrilases. These enzymes have different substrate specificities and catalytic mechanisms but share the common ability to hydrolyze amide bonds.

Proteases, for example, are a major group of amidohydrolases that specifically cleave peptide bonds in proteins. They are involved in various physiological processes, such as protein degradation, digestion, and regulation of biological pathways. Esterases and lipases hydrolyze ester bonds in various substrates, including lipids and other organic compounds. Nitrilases convert nitriles into carboxylic acids and ammonia by cleaving the nitrile bond (C≡N) through hydrolysis.

Amidohydrolases are found in various organisms, from bacteria to humans, and have diverse applications in industry, agriculture, and medicine. For instance, they can be used for the production of pharmaceuticals, biofuels, detergents, and other chemicals. Additionally, inhibitors of amidohydrolases can serve as therapeutic agents for treating various diseases, such as cancer, viral infections, and neurodegenerative disorders.

Pneumococcal infections are illnesses caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium can infect different parts of the body, including the lungs (pneumonia), blood (bacteremia or sepsis), and the covering of the brain and spinal cord (meningitis). Pneumococcal infections can also cause ear infections and sinus infections. The bacteria spread through close contact with an infected person, who may spread the bacteria by coughing or sneezing. People with weakened immune systems, children under 2 years of age, adults over 65, and those with certain medical conditions are at increased risk for developing pneumococcal infections.

Clindamycin is a antibiotic medication used to treat a variety of bacterial infections. It is a type of antibiotic known as a lincosamide, which works by binding to the bacterial ribosome and inhibiting protein synthesis. This leads to the death of the bacteria and helps to clear the infection.

Clindamycin is effective against a wide range of gram-positive and some anaerobic bacteria, making it a useful antibiotic for treating many different types of infections, including skin and soft tissue infections, bone and joint infections, respiratory infections, and dental infections. It is also sometimes used to treat certain types of bacterial vaginal infections.

Like all antibiotics, clindamycin should be used only under the direction of a healthcare provider, as misuse can lead to antibiotic resistance. Additionally, clindamycin can cause side effects such as diarrhea, nausea, and vomiting, and it may increase the risk of developing a serious intestinal infection called Clostridioides difficile-associated diarrhea (CDAD). It is important to follow your healthcare provider's instructions carefully when taking this medication.

Bacterial outer membrane proteins (OMPs) are a type of protein found in the outer membrane of gram-negative bacteria. The outer membrane is a unique characteristic of gram-negative bacteria, and it serves as a barrier that helps protect the bacterium from hostile environments. OMPs play a crucial role in maintaining the structural integrity and selective permeability of the outer membrane. They are involved in various functions such as nutrient uptake, transport, adhesion, and virulence factor secretion.

OMPs are typically composed of beta-barrel structures that span the bacterial outer membrane. These proteins can be classified into several groups based on their size, function, and structure. Some of the well-known OMP families include porins, autotransporters, and two-partner secretion systems.

Porins are the most abundant type of OMPs and form water-filled channels that allow the passive diffusion of small molecules, ions, and nutrients across the outer membrane. Autotransporters are a diverse group of OMPs that play a role in bacterial pathogenesis by secreting virulence factors or acting as adhesins. Two-partner secretion systems involve the cooperation between two proteins to transport effector molecules across the outer membrane.

Understanding the structure and function of bacterial OMPs is essential for developing new antibiotics and therapies that target gram-negative bacteria, which are often resistant to conventional treatments.

Typhoid fever is an acute illness caused by the bacterium Salmonella enterica serovar Typhi. It is characterized by sustained fever, headache, constipation or diarrhea, rose-colored rash (in some cases), abdominal pain, and weakness. The bacteria are spread through contaminated food, water, or direct contact with an infected person's feces. If left untreated, typhoid fever can lead to severe complications and even be fatal. It is diagnosed through blood, stool, or urine tests and treated with antibiotics. Vaccination is available for prevention.

Antibiotic prophylaxis refers to the use of antibiotics to prevent infection from occurring in the first place, rather than treating an existing infection. This practice is commonly used before certain medical procedures or surgeries that have a high risk of infection, such as joint replacements, heart valve surgery, or organ transplants. The goal of antibiotic prophylaxis is to reduce the risk of infection by introducing antibiotics into the body before bacteria have a chance to multiply and cause an infection.

The choice of antibiotic for prophylaxis depends on several factors, including the type of procedure being performed, the patient's medical history and allergies, and the most common types of bacteria that can cause infection in that particular situation. The antibiotic is typically given within one hour before the start of the procedure, and may be continued for up to 24 hours afterward, depending on the specific guidelines for that procedure.

It's important to note that antibiotic prophylaxis should only be used when it is truly necessary, as overuse of antibiotics can contribute to the development of antibiotic-resistant bacteria. Therefore, the decision to use antibiotic prophylaxis should be made carefully and in consultation with a healthcare provider.

Fleroxacin is a fluoroquinolone antibiotic that is used to treat various types of bacterial infections, including respiratory, urinary tract, and skin infections. It works by inhibiting the DNA gyrase enzyme in bacteria, which is necessary for their replication and survival.

Fleroxacin has a broad spectrum of activity against both gram-positive and gram-negative bacteria, making it useful for treating a variety of infections caused by these organisms. However, like other fluoroquinolones, fleroxacin carries a risk of serious side effects, including tendinitis, tendon rupture, nerve damage, and other central nervous system effects. Therefore, its use is generally reserved for situations where other antibiotics are not effective or appropriate.

Fleroxacin is available in oral tablet form and is typically taken twice daily with a full glass of water. It should be taken on an empty stomach, at least one hour before or two hours after meals. The dosage and duration of treatment will depend on the type and severity of the infection being treated, as well as the patient's overall health status.

It is important to note that fleroxacin, like all antibiotics, should only be used under the guidance of a healthcare professional, and should not be used for viral infections such as the common cold or flu. Misuse of antibiotics can lead to antibiotic resistance, which makes it more difficult to treat bacterial infections in the future.

Ticarcillin is an antibiotic medication that belongs to the class of drugs called penicillins. It is primarily used to treat infections caused by susceptible bacteria. Ticarcillin has activity against various gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa.

The drug works by inhibiting the synthesis of bacterial cell walls, leading to bacterial death. It is often administered intravenously in a hospital setting due to its poor oral bioavailability. Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, as well as allergic reactions, including rash and itching.

It's important to note that the use of ticarcillin should be based on the results of bacterial culture and sensitivity testing to ensure its effectiveness against the specific bacteria causing the infection. Additionally, healthcare providers should monitor renal function during treatment, as ticarcillin can affect kidney function in some patients.

Pneumococcal meningitis is a specific type of bacterial meningitis, which is an inflammation of the membranes covering the brain and spinal cord (meninges). It is caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium is commonly found in the upper respiratory tract and middle ear fluid of healthy individuals. However, under certain circumstances, it can invade the bloodstream and reach the meninges, leading to meningitis.

Pneumococcal meningitis is a serious and potentially life-threatening condition that requires immediate medical attention. Symptoms may include sudden onset of fever, severe headache, stiff neck, nausea, vomiting, confusion, and sensitivity to light (photophobia). In some cases, it can also lead to complications such as hearing loss, brain damage, or even death if not treated promptly and effectively.

Treatment typically involves the use of antibiotics that are effective against pneumococcus, such as ceftriaxone or vancomycin. In some cases, corticosteroids may also be used to reduce inflammation and prevent complications. Prevention measures include vaccination with the pneumococcal conjugate vaccine (PCV13) or the pneumococcal polysaccharide vaccine (PPSV23), which can help protect against pneumococcal infections, including meningitis.

Community-acquired infections are those that are acquired outside of a healthcare setting, such as in one's own home or community. These infections are typically contracted through close contact with an infected person, contaminated food or water, or animals. Examples of community-acquired infections include the common cold, flu, strep throat, and many types of viral and bacterial gastrointestinal infections.

These infections are different from healthcare-associated infections (HAIs), which are infections that patients acquire while they are receiving treatment for another condition in a healthcare setting, such as a hospital or long-term care facility. HAIs can be caused by a variety of factors, including contact with contaminated surfaces or equipment, invasive medical procedures, and the use of certain medications.

It is important to note that community-acquired infections can also occur in healthcare settings if proper infection control measures are not in place. Healthcare providers must take steps to prevent the spread of these infections, such as washing their hands regularly, using personal protective equipment (PPE), and implementing isolation precautions for patients with known or suspected infectious diseases.

Optical rotatory dispersion (ORD) is a phenomenon in which plane-polarized light is rotated as it passes through an optically active substance. It is a measure of the difference in refractive index between left and right circularly polarized light, and is dependent on the wavelength of the light. ORD is used to determine the optical purity and absolute configuration of chiral molecules, particularly in the field of stereochemistry. The magnitude and sign of the rotation can provide information about the concentration and type of optically active compound present in a sample.

DNA Sequence Analysis is the systematic determination of the order of nucleotides in a DNA molecule. It is a critical component of modern molecular biology, genetics, and genetic engineering. The process involves determining the exact order of the four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - in a DNA molecule or fragment. This information is used in various applications such as identifying gene mutations, studying evolutionary relationships, developing molecular markers for breeding, and diagnosing genetic diseases.

The process of DNA Sequence Analysis typically involves several steps, including DNA extraction, PCR amplification (if necessary), purification, sequencing reaction, and electrophoresis. The resulting data is then analyzed using specialized software to determine the exact sequence of nucleotides.

In recent years, high-throughput DNA sequencing technologies have revolutionized the field of genomics, enabling the rapid and cost-effective sequencing of entire genomes. This has led to an explosion of genomic data and new insights into the genetic basis of many diseases and traits.

Gram-positive bacterial infections refer to illnesses or diseases caused by Gram-positive bacteria, which are a group of bacteria that turn purple when stained using the Gram stain method. This staining technique is used in microbiology to differentiate between two main types of bacteria based on their cell wall composition.

Gram-positive bacteria have a thick layer of peptidoglycan in their cell walls, which retains the crystal violet stain used in the Gram staining process. Some common examples of Gram-positive bacteria include Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis.

Gram-positive bacterial infections can range from mild skin infections to severe and life-threatening conditions such as pneumonia, meningitis, and sepsis. The symptoms of these infections depend on the type of bacteria involved and the location of the infection in the body. Treatment typically involves the use of antibiotics that are effective against Gram-positive bacteria, such as penicillin, vancomycin, or clindamycin. However, the emergence of antibiotic resistance among Gram-positive bacteria is a growing concern and can complicate treatment in some cases.

"Acremonium" is a genus of filamentous fungi that are commonly found in soil, decaying vegetation, and water. Some species of Acremonium can cause infections in humans, particularly in individuals with weakened immune systems. These infections can affect various organs and tissues, including the skin, nails, lungs, and eyes.

The medical definition of "Acremonium" is therefore a type of fungus that can cause a variety of infectious diseases, particularly in immunocompromised individuals. It's important to note that Acremonium infections are relatively rare, but they can be serious and require prompt medical treatment.

Amoxicillin is a type of antibiotic known as a penicillin. It works by interfering with the ability of bacteria to form cell walls, which is necessary for their growth and survival. By disrupting this process, amoxicillin can kill bacteria and help to clear up infections.

Amoxicillin is used to treat a variety of bacterial infections, including respiratory tract infections, ear infections, skin infections, and urinary tract infections. It is available as a tablet, capsule, chewable tablet, or liquid suspension, and is typically taken two to three times a day.

Like all antibiotics, amoxicillin should be used only under the direction of a healthcare provider, and it is important to take the full course of treatment as prescribed, even if symptoms improve before the medication is finished. Misuse of antibiotics can lead to the development of drug-resistant bacteria, which can make infections more difficult to treat in the future.

Chloramphenicol is an antibiotic medication that is used to treat a variety of bacterial infections. It works by inhibiting the ability of bacteria to synthesize proteins, which essential for their growth and survival. This helps to stop the spread of the infection and allows the body's immune system to clear the bacteria from the body.

Chloramphenicol is a broad-spectrum antibiotic, which means that it is effective against many different types of bacteria. It is often used to treat serious infections that have not responded to other antibiotics. However, because of its potential for serious side effects, including bone marrow suppression and gray baby syndrome, chloramphenicol is usually reserved for use in cases where other antibiotics are not effective or are contraindicated.

Chloramphenicol can be given by mouth, injection, or applied directly to the skin in the form of an ointment or cream. It is important to take or use chloramphenicol exactly as directed by a healthcare provider, and to complete the full course of treatment even if symptoms improve before all of the medication has been taken. This helps to ensure that the infection is fully treated and reduces the risk of antibiotic resistance.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

I'm sorry for any confusion, but "Spain" is not a medical term. It is a country located in southwestern Europe. If you have any questions about medical terms or topics, I would be happy to help answer them.

Gentamicin is an antibiotic that belongs to the class of aminoglycosides. It is used to treat various types of bacterial infections, including:

* Gram-negative bacterial infections, such as those caused by Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis
* Certain Gram-positive bacterial infections, such as those caused by Staphylococcus aureus and Streptococcus pyogenes

Gentamicin works by binding to the 30S subunit of the bacterial ribosome, which inhibits protein synthesis and ultimately leads to bacterial cell death. It is typically given via injection (intramuscularly or intravenously) and is often used in combination with other antibiotics to treat serious infections.

Like all aminoglycosides, gentamicin can cause kidney damage and hearing loss, especially when used for long periods of time or at high doses. Therefore, monitoring of drug levels and renal function is recommended during treatment.

I'm sorry for any confusion, but "Mandelic Acids" is not a recognized medical term or concept in dermatology or medicine. Mandelic acid, however, is a type of chemical compound used in skincare products for various purposes such as exfoliation and reducing hyperpigmentation. It is an aromatic hydroxyacetic acid derived from mandelic almonds. If you have any questions about skincare ingredients or treatments, I'd be happy to help clarify those for you!

Acinetobacter infections are caused by bacteria that can be found in various environments, such as soil, water, and healthcare facilities. These bacteria can cause a range of illnesses, from mild skin infections to serious respiratory and bloodstream infections. They are often resistant to multiple antibiotics, making them difficult to treat.

Acinetobacter baumannii is the species most commonly associated with human infection. It is known for its ability to survive on dry surfaces for extended periods of time, which can contribute to its spread in healthcare settings. Infections caused by Acinetobacter are a particular concern in critically ill patients, such as those in intensive care units, and in individuals with weakened immune systems.

Symptoms of an Acinetobacter infection depend on the site of infection but may include fever, cough, shortness of breath, wound drainage, or skin redness or swelling. Treatment typically involves the use of antibiotics that are still effective against the bacteria, which can be determined through laboratory testing. In some cases, infection control measures, such as contact precautions and environmental cleaning, may also be necessary to prevent the spread of Acinetobacter in healthcare settings.

In the context of pharmacology, "half-life" refers to the time it takes for the concentration or amount of a drug in the body to be reduced by half during its elimination phase. This is typically influenced by factors such as metabolism and excretion rates of the drug. It's a key factor in determining dosage intervals and therapeutic effectiveness of medications, as well as potential side effects or toxicity risks.

"Escherichia" is a genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the intestines of warm-blooded organisms. The most well-known species in this genus is "Escherichia coli," or "E. coli," which is a normal inhabitant of the human gut and is often used as an indicator of fecal contamination in water and food. Some strains of E. coli can cause illness, however, including diarrhea, urinary tract infections, and meningitis. Other species in the genus "Escherichia" are less well-known and are not typically associated with disease.

Blood proteins, also known as serum proteins, are a group of complex molecules present in the blood that are essential for various physiological functions. These proteins include albumin, globulins (alpha, beta, and gamma), and fibrinogen. They play crucial roles in maintaining oncotic pressure, transporting hormones, enzymes, vitamins, and minerals, providing immune defense, and contributing to blood clotting.

Albumin is the most abundant protein in the blood, accounting for about 60% of the total protein mass. It functions as a transporter of various substances, such as hormones, fatty acids, and drugs, and helps maintain oncotic pressure, which is essential for fluid balance between the blood vessels and surrounding tissues.

Globulins are divided into three main categories: alpha, beta, and gamma globulins. Alpha and beta globulins consist of transport proteins like lipoproteins, hormone-binding proteins, and enzymes. Gamma globulins, also known as immunoglobulins or antibodies, are essential for the immune system's defense against pathogens.

Fibrinogen is a protein involved in blood clotting. When an injury occurs, fibrinogen is converted into fibrin, which forms a mesh to trap platelets and form a clot, preventing excessive bleeding.

Abnormal levels of these proteins can indicate various medical conditions, such as liver or kidney disease, malnutrition, infections, inflammation, or autoimmune disorders. Blood protein levels are typically measured through laboratory tests like serum protein electrophoresis (SPE) and immunoelectrophoresis (IEP).

Ciprofloxacin is a fluoroquinolone antibiotic that is used to treat various types of bacterial infections, including respiratory, urinary, and skin infections. It works by inhibiting the bacterial DNA gyrase, which is an enzyme necessary for bacterial replication and transcription. This leads to bacterial cell death. Ciprofloxacin is available in oral and injectable forms and is usually prescribed to be taken twice a day. Common side effects include nausea, diarrhea, and headache. It may also cause serious adverse reactions such as tendinitis, tendon rupture, peripheral neuropathy, and central nervous system effects. It is important to note that ciprofloxacin should not be used in patients with a history of hypersensitivity to fluoroquinolones and should be used with caution in patients with a history of seizures, brain injury, or other neurological conditions.

A Serum Bactericidal Test (SBT) is a laboratory test used to determine the ability of a patient's serum to kill specific bacteria. The test measures the concentration of complement and antibodies in the serum that can contribute to bacterial killing. In this test, a standardized quantity of bacteria is mixed with serial dilutions of the patient's serum and incubated for a set period. After incubation, the mixture is plated on agar media, and the number of surviving bacteria is counted after a suitable incubation period. The bactericidal titer is defined as the reciprocal of the highest dilution of serum that kills 99.9% of the initial inoculum.

The SBT is often used to evaluate the efficacy of antibiotic therapy, assess immune function, and diagnose infections caused by bacteria with reduced susceptibility to complement-mediated killing. The test can also be used to monitor the response to immunotherapy or vaccination and to identify patients at risk for recurrent infections due to impaired serum bactericidal activity.

It is important to note that the SBT has some limitations, including its variability between laboratories, the need for specialized equipment and expertise, and the potential for false-positive or false-negative results. Therefore, the test should be interpreted in conjunction with other clinical and laboratory data.

DNA fingerprinting, also known as DNA profiling or genetic fingerprinting, is a laboratory technique used to identify and compare the unique genetic makeup of individuals by analyzing specific regions of their DNA. This method is based on the variation in the length of repetitive sequences of DNA called variable number tandem repeats (VNTRs) or short tandem repeats (STRs), which are located at specific locations in the human genome and differ significantly among individuals, except in the case of identical twins.

The process of DNA fingerprinting involves extracting DNA from a sample, amplifying targeted regions using the polymerase chain reaction (PCR), and then separating and visualizing the resulting DNA fragments through electrophoresis. The fragment patterns are then compared to determine the likelihood of a match between two samples.

DNA fingerprinting has numerous applications in forensic science, paternity testing, identity verification, and genealogical research. It is considered an essential tool for providing strong evidence in criminal investigations and resolving disputes related to parentage and inheritance.

Tonsillitis is a medical condition characterized by inflammation and infection of the tonsils, which are two masses of lymphoid tissue located on either side of the back of the throat. The tonsils serve as a defense mechanism against inhaled or ingested pathogens; however, they can become infected themselves, leading to tonsillitis.

The inflammation of the tonsils is often accompanied by symptoms such as sore throat, difficulty swallowing, fever, swollen and tender lymph nodes in the neck, cough, headache, and fatigue. In severe or recurrent cases, a tonsillectomy (surgical removal of the tonsils) may be recommended to alleviate symptoms and prevent complications.

Tonsillitis can be caused by both viral and bacterial infections, with group A streptococcus being one of the most common bacterial causes. It is typically diagnosed based on a physical examination and medical history, and sometimes further confirmed through laboratory tests such as a throat swab or rapid strep test. Treatment may include antibiotics for bacterial tonsillitis, pain relievers, and rest to aid in recovery.

A "University Hospital" is a type of hospital that is often affiliated with a medical school or university. These hospitals serve as major teaching institutions where medical students, residents, and fellows receive their training and education. They are equipped with advanced medical technology and resources to provide specialized and tertiary care services. University hospitals also conduct research and clinical trials to advance medical knowledge and practices. Additionally, they often treat complex and rare cases and provide a wide range of medical services to the community.

Peritonitis is a medical condition characterized by inflammation of the peritoneum, which is the serous membrane that lines the inner wall of the abdominal cavity and covers the abdominal organs. The peritoneum has an important role in protecting the abdominal organs and providing a smooth surface for them to move against each other.

Peritonitis can occur as a result of bacterial or fungal infection, chemical irritation, or trauma to the abdomen. The most common cause of peritonitis is a rupture or perforation of an organ in the abdominal cavity, such as the appendix, stomach, or intestines, which allows bacteria from the gut to enter the peritoneal cavity.

Symptoms of peritonitis may include abdominal pain and tenderness, fever, nausea and vomiting, loss of appetite, and decreased bowel movements. In severe cases, peritonitis can lead to sepsis, a life-threatening condition characterized by widespread inflammation throughout the body.

Treatment for peritonitis typically involves antibiotics to treat the infection, as well as surgical intervention to repair any damage to the abdominal organs and remove any infected fluid or tissue from the peritoneal cavity. In some cases, a temporary or permanent drain may be placed in the abdomen to help remove excess fluid and promote healing.

Magnetic Resonance Spectroscopy (MRS) is a non-invasive diagnostic technique that provides information about the biochemical composition of tissues, including their metabolic state. It is often used in conjunction with Magnetic Resonance Imaging (MRI) to analyze various metabolites within body tissues, such as the brain, heart, liver, and muscles.

During MRS, a strong magnetic field, radio waves, and a computer are used to produce detailed images and data about the concentration of specific metabolites in the targeted tissue or organ. This technique can help detect abnormalities related to energy metabolism, neurotransmitter levels, pH balance, and other biochemical processes, which can be useful for diagnosing and monitoring various medical conditions, including cancer, neurological disorders, and metabolic diseases.

There are different types of MRS, such as Proton (^1^H) MRS, Phosphorus-31 (^31^P) MRS, and Carbon-13 (^13^C) MRS, each focusing on specific elements or metabolites within the body. The choice of MRS technique depends on the clinical question being addressed and the type of information needed for diagnosis or monitoring purposes.

A drug prescription is a written or electronic order provided by a licensed healthcare professional, such as a physician, dentist, or advanced practice nurse, to a pharmacist that authorizes the preparation and dispensing of a specific medication for a patient. The prescription typically includes important information such as the patient's name and date of birth, the name and strength of the medication, the dosage regimen, the duration of treatment, and any special instructions or precautions.

Prescriptions serve several purposes, including ensuring that patients receive the appropriate medication for their medical condition, preventing medication errors, and promoting safe and effective use of medications. They also provide a legal record of the medical provider's authorization for the pharmacist to dispense the medication to the patient.

There are two main types of prescriptions: written prescriptions and electronic prescriptions. Written prescriptions are handwritten or printed on paper, while electronic prescriptions are transmitted electronically from the medical provider to the pharmacy. Electronic prescriptions are becoming increasingly common due to their convenience, accuracy, and security.

It is important for patients to follow the instructions provided on their prescription carefully and to ask their healthcare provider or pharmacist any questions they may have about their medication. Failure to follow a drug prescription can result in improper use of the medication, which can lead to adverse effects, treatment failure, or even life-threatening situations.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Heterocyclic compounds are organic compounds that contain at least one atom within the ring structure, other than carbon, such as nitrogen, oxygen, sulfur or phosphorus. These compounds make up a large class of naturally occurring and synthetic materials, including many drugs, pigments, vitamins, and antibiotics. The presence of the heteroatom in the ring can have significant effects on the physical and chemical properties of the compound, such as its reactivity, stability, and bonding characteristics. Examples of heterocyclic compounds include pyridine, pyrimidine, and furan.

Oxacillin is a type of antibiotic known as a penicillinase-resistant penicillin. It is used to treat infections caused by bacteria that are resistant to other types of penicillins. Oxacillin is commonly used to treat infections of the skin, soft tissue, and bone.

Here is the medical definition of oxacillin:

Oxacillin is a semisynthetic antibiotic derived from penicillin that is resistant to staphylococcal penicillinases. It is used to treat infections caused by susceptible strains of staphylococci and some streptococci, including penicillinase-producing staphylococci. Oxacillin is available as a sterile powder for injection or as a oral capsule.

It is important to note that the overuse or misuse of antibiotics like oxacillin can lead to the development of antibiotic resistance, which makes infections harder to treat. It's essential to use antibiotics only when necessary and as directed by a healthcare professional.

Amikacin is a type of antibiotic known as an aminoglycoside, which is used to treat various bacterial infections. It works by binding to the 30S subunit of the bacterial ribosome, inhibiting protein synthesis and ultimately leading to bacterial cell death. Amikacin is often used to treat serious infections caused by Gram-negative bacteria, including Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae. It may be given intravenously or intramuscularly, depending on the severity and location of the infection. As with all antibiotics, amikacin should be used judiciously to prevent the development of antibiotic resistance.

Cecal diseases refer to medical conditions that affect the cecum, which is a pouch-like structure located at the junction of the small and large intestines. The cecum plays an important role in digestion, particularly in the fermentation of certain types of food.

There are several different types of cecal diseases, including:

1. Cecal volvulus: This is a rare condition in which the cecum twists on itself, cutting off blood flow and causing severe pain and other symptoms.
2. Diverticulitis: This occurs when small pouches called diverticula form in the wall of the cecum and become inflamed or infected.
3. Appendicitis: Although not strictly a cecal disease, the appendix is a small tube-like structure that branches off from the cecum. Inflammation of the appendix (appendicitis) can cause severe pain in the lower right abdomen and may require surgical removal of the appendix.
4. Crohn's disease: This is a chronic inflammatory bowel disease that can affect any part of the digestive tract, including the cecum.
5. Tuberculosis: The cecum can also be affected by tuberculosis, which is a bacterial infection that primarily affects the lungs but can spread to other parts of the body.
6. Cancer: Although rare, cancer can also affect the cecum, leading to symptoms such as abdominal pain, bloating, and changes in bowel habits.

Treatment for cecal diseases depends on the specific condition and its severity. Treatment options may include antibiotics, surgery, or other medical interventions. If you are experiencing symptoms that may be related to a cecal disease, it is important to seek medical attention promptly.

The first cephalosporins were designated first-generation cephalosporins, whereas, later, more extended-spectrum cephalosporins ... "cephalosporin". Merriam-Webster Dictionary. "cephalosporin - definition of cephalosporin in English from the Oxford dictionary ... Cephalosporins were discovered in 1945, and first sold in 1964. The aerobic mold which yielded cephalosporin C was found in the ... The cephalosporin nucleus can be modified to gain different properties. Cephalosporins are sometimes grouped into "generations ...
The cephalosporin class is very extensive so a good classification system is necessary to distinguish different cephalosporins ... First generation cephalosporins were the first cephalosporins on the market. They have good antimicrobial activity against gram ... Cephalothin, a first generation cephalosporin for parenteral use was the first cephalosporin to become available for patients ... The first chemical compounds of the cephalosporin group were isolated from Cephalosporium acremonium, a cephalosporin-producing ...
... was a lead compound for the discovery and production of many other cephalosporins. Cephalosporins are drugs ... Cephalosporin C is an antibiotic of the cephalosporin class. It was isolated from a fungus of the genus Acremonium and first ... Cephalosporin C is the product of the biosynthesis pathway of third generation cephalosporins. This is done by exchanging the ... became some of the first marketed cephalosporin antibiotic drugs. Cephalosporin C strongly absorbs ultraviolet light, is stable ...
... cephalosporin C acetylase, cephalosporin acetylesterase, cephalosporin C acetylesterase, cephalosporin C acetyl-esterase, and ... The enzyme cephalosporin-C deacetylase (EC 3.1.1.41) catalyzes the reaction cephalosporin C + H2O ⇌ {\displaystyle \ ... The systematic name is cephalosporin-C acetylhydrolase. Other names in common use include cephalosporin C acetyl-hydrolase, ... Fujisawa Y, Shirafugi H, Kida M, Nara K, Yoneda M, Kanzaki T (1973). "New findings on cephalosporin C biosynthesis". Nat. New ...
Other names in common use include cephalosporin C aminotransferase, and L-alanine:cephalosporin-C aminotransferase. This enzyme ... In enzymology, a cephalosporin-C transaminase (EC 2.6.1.74) is an enzyme that catalyzes the chemical reaction (7R)-7-(5-carboxy ... The systematic name of this enzyme class is cephalosporin-C:2-oxoglutarate aminotransferase. ... whereas its two products are cephalosporin C and 2-oxoglutarate. This enzyme belongs to the family of transferases, ...
Cephalosporins work as bactericidal antibiotics; that by binding to penicillin-binding proteins (PBPs), inhibit the last step ... Second generation cephalosporins are more effective in treating Gram-negative bacilli compared to first generation ... Cefuroxime axetil, sold under the brand name Ceftin among others, is a second generation oral cephalosporin antibiotic. It is ... Bui T, Preuss CV (2020). "Cephalosporins". StatPearls. StatPearls Publishing. PMID 31855361. Retrieved 2020-04-23. Perry CM, ...
However, ceftazidime is less effective for S. aureus than first and second generation cephalosporins. Also. cephalosporins ... Third-generation cephalosporins differ from earlier generations in the presence of a C=N-OCH3 group in their chemical structure ... It is in the third-generation cephalosporin family of medications and works by interfering with the bacteria's cell wall. ... In addition to the syn-configuration of the imino side chain, compared to other third-generation cephalosporins, the more ...
Cephalosporins antibiotics. Discovered by Giuseppe Brotzu in 1948. Artificial insemination, although previously theorized, only ...
January 1977). "Semisynthetic cephalosporins. Synthesis and structure-activity relationships of analogues with 7-acyl groups ... Cefazaflur (INN) is a first-generation cephalosporin antibiotic. Cefazaflur stands out among this group of analogues because it ...
From salvarsan to cephalosporins". J Invest Surg. 25 (2): 67-77. doi:10.3109/08941939.2012.664099. PMID 22439833. S2CID ... Abraham EP (1987). "Cephalosporins 1945-1986". Drugs. 34 Suppl 2 (Supplement 2): 1-14. doi:10.2165/00003495-198700342-00003. ... Hamilton-Miller JM (March 2008). "Development of the semi-synthetic penicillins and cephalosporins". Int. J. Antimicrob. Agents ... aftermath of World War II saw an explosion in the discovery of new classes of antibacterial drugs including the cephalosporins ...
"The Use of Cephalosporins in Penicillin-allergic Patients". www.medscape.com. Archived from the original on 14 November 2015. ... It is a third-generation cephalosporin that works by preventing bacteria from making a cell wall. Ceftriaxone was patented in ... Ceftriaxone is a third-generation antibiotic from the cephalosporin family of antibiotics. It is within the β-lactam family of ... Ceftriaxone, sold under the brand name Rocephin, is a third-generation cephalosporin antibiotic used for the treatment of a ...
It should not be used in pregnant or lactating animals or in animals with a history of allergies to penicillin or cephalosporin ... Cefovecin (INN) is an antibiotic of the cephalosporin class, licensed for the treatment of skin infections in cats and dogs. It ... Cephalosporins and cephamycins". Small animal clinical pharmacology (2nd ed.). Edinburgh: Saunders/Elsevier. pp. 164-168. ISBN ... Cefovecin is a broad-spectrum, third-generation cephalosporin antibiotic administered by subcutaneous injection. It is used to ...
... (INN, codenamed S-1090) is an orally-active cephalosporin antibiotic. It was developed in Japan and first described ... Cazzola M (February 2000). "Novel oral cephalosporins". Expert Opin Investig Drugs. 9 (2): 237-46. doi:10.1517/13543784.9.2.237 ... a new oral cephalosporin". Antimicrob Agents Chemother. 39 (11): 2544-51. doi:10.1128/aac.39.11.2544. PMC 162981. PMID 8585742 ... Cephalosporin antibiotics, Ketoximes, Thiazoles, Triazoles, All stub articles, Antibiotic stubs). ...
Morin, Robert B.; Gorman, Marvin (2014). Penicillins and Cephalosporins. Academic Press. pp. xxii. ISBN 978-1-4832-7719-6. Ward ...
From salvarsan to cephalosporins". Journal of Investigative Surgery. 25 (2): 67-77. doi:10.3109/08941939.2012.664099. PMID ... Several anti-infective medications have been derived from fungi including penicillin and the cephalosporins (antibacterial ...
... is a broad-spectrum cephalosporin antibiotic. Dunn GL, Hoover JR, Berges DA, Taggart JJ, Davis LD, Dietz EM, et al ... January 1976). "Orally active 7-phenylglycyl cephalosporins. Structure-activity studies related to cefatrizine (SK&F 60771)". ... Cephalosporin antibiotics, Triazoles, Phenols, Acetamides, All stub articles, Antibiotic stubs). ...
For example, bacterial resistance against beta-lactam antibiotics (such as penicillin and cephalosporins) can be circumvented ... Barber M, Waterworth PM (August 1964). "Penicillinase-resistant Penicillins and Cephalosporins". British Medical Journal. 2 ( ...
Kelkar PS, Li JT (September 2001). "Cephalosporin allergy". The New England Journal of Medicine. 345 (11): 804-809. doi:10.1056 ...
... is a third-generation cephalosporin antibiotic that is active against Pseudomonas aeruginosa and was discovered by ... Smith BR (1984). "Cefsulodin and ceftazidime, two antipseudomonal cephalosporins". Clinical Pharmacy. 3 (4): 373-85. PMID ... Cephalosporin antibiotics, Isonicotinamides, Takeda Pharmaceutical Company brands, Sulfonates). ...
The bacteria remain susceptible to aminoglycosides and some cephalosporins, and varying degrees of inhibition of the beta- ... and cephalosporins, the choice depending upon antibiotic susceptibility testing, the person's health condition, medical history ... treatment consists of third generation cephalosporins.[medical citation needed] Hypervirulent (hvKp) is a rather recent K ...
Broad-spectrum fourth generation injectable aminothiazolyl cephalosporin. Cefotaxime (1) is a potent cephalosporin antibiotic ... Although fourth-generation cephalosporin resistance is very rare, they are active against bacteria carrying the AmpC-type β- ... Since the late 1990s, the US and EU have surveyed and gathered data for fourth-generation cephalosporins for both human and ... Hypersensitivity reactions to cephalosporins occur rarely. The product does not contain an antimicrobial preservative. To ...
Flynn EH (1972). Cephalosporins and Penicillins : Chemistry and Biology. New York and London: Academic Press. Hosseyni S, ... cephalosporins, carbapenems, and monobactams, which are, therefore, also called β-lactam antibiotics. Nearly all of these ... most β-lactam research was concerned with the penicillin and cephalosporin groups, but since then, a wide variety of structures ...
Hydrolysis of cephalosporin C, isolation of 7-aminocephalosporanic acid and the addition of side chains opened the possibility ... Interest in studying cephalosporins was brought about by some unusual properties of cephaloridine. This antibiotic stands in ... Turck M (1982). "Cephalosporins and related antibiotics: an overview". Reviews of Infectious Diseases. 4 Suppl: S281-7. doi: ... Cephaloridine is a cephalosporin compound with pyridinium-1-ylmethyl and 2-thienylacetamido side groups. The molecular nucleus ...
The cephalosporin ceftaroline and the lipoglycopeptides oritavancin and telavancin for the treatment of acute bacterial skin ... New cephalosporin-lactamase inhibitor combinations also approved include ceftazidime-avibactam and ceftolozane-avibactam for ... Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with ... Ceftaroline/avibactam (CPT-avibactam; ceftaroline/NXL104): Anti-MRSA cephalosporin/ β-lactamase inhibitor combination (cell ...
It is a cephalosporin, which have been known to induce psychotic side effects, including hallucinations and paranoia. However, ... McDonald, C. Ann.; Addis, Steven (October 2003). "Cephalosporin-induced psychosis". Australian & New Zealand Journal of ...
It is also the source of cephalosporins. Lalchhandama, K. (2020). "Reappraising Fleming's snot and mould". Science Vision. 20 ( ...
Hamilton-Miller, J. M. (March 2008). "Development of the semisynthetic penicillins and cephalosporins". International Journal ... the cephalosporins, still retain it at the centre of their structures. β-lactam penicillins became the most widely used ...
Susceptibility to tetracyclines and cephalosporins is variable. A Spanish study, involving enteric pathogens also found that 32 ...
Their initial evaluation of the antibiotic activity of cephalosporin C was that it was low, so Abraham sent Florey, who was in ... The Oxford team patented their work on cephalosporins and assigned the patents to the NRDC. By 1978, the annual world sales of ... The Oxford team analysed the chemical properties of the cephalosporin ring system, opening the door to the production of ... "Everybody I have questioned who was involved in the development of cephalosporin C," science writer David Wilson reported, " ...
Petri WA (2011). "Penicillins, Cephalosporins, and Other Beta-Lactam Antibiotics". In Brunton L, Chabner B, Knollman B (eds.). ... It can be made less effective by other antibiotic, such as chloramphenicol, erythromycin, cephalosporins, and tetracyclines. ...
The first cephalosporins were designated first-generation cephalosporins, whereas, later, more extended-spectrum cephalosporins ... "cephalosporin". Merriam-Webster Dictionary. "cephalosporin - definition of cephalosporin in English from the Oxford dictionary ... Cephalosporins were discovered in 1945, and first sold in 1964. The aerobic mold which yielded cephalosporin C was found in the ... The cephalosporin nucleus can be modified to gain different properties. Cephalosporins are sometimes grouped into "generations ...
Cephalosporins are a critical component of CDC-recommended gonorrhea treatment; however, declining cephalosporin susceptibility ... to cephalosporins are increasing, suggesting that susceptibility to cephalosporins might be declining. The prevalence of ... consider enhancing surveillance for cephalosporin-resistant gonorrhea, and report gonorrhea cases with cephalosporin treatment ... Cephalosporin Susceptibility Among Neisseria gonorrhoeae Isolates --- United States, 2000--2010. Neisseria gonorrhoeae is a ...
siderophore cephalosporin. cefiderocol. A new class of antibiotic: an injectable siderophore cephalosporin that combines a ... Fourth-generation cephalosporin with good gram-negative coverage. Similar to third-generation cephalosporins but has better ... Third-generation cephalosporins frequently show good in vitro activity against these organisms, but, as explained above, a ... A new cephalosporin beta-lactamase-inhibitor antibiotic with extended activity against many gram-negative bacilli. Avibactam is ...
Global Cephalosporin Market Report 2022 comes with the extensive industry analysis by Introspective Market Research wit ... Second Generation Cephalosporin. Third Generation Cephalosporin. Fourth Generation Cephalosporin. By Application, Cephalosporin ... Second Generation Cephalosporin. Third Generation Cephalosporin. Fourth Generation Cephalosporin. By Application, Cephalosporin ... Global Cephalosporin Market Research Report 2023. Abstract Global Cephalosporin Market Overview:. Global Cephalosporin Market ...
A new cephalosporin with a highly reactive beta-lactam ring was found to give an immediate color change in the presence of beta ... A new cephalosporin with a highly reactive beta-lactam ring was found to give an immediate color change in the presence of beta ... Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate Antimicrob Agents Chemother. 1972 ... where cephalosporins normally have no absorption. The development of color is thought to be a consequence of the beta-lactam ...
p, The cephalosporin drugs market was valued at approximately USD 14,010 million in 2020, and it is expected to reach USD ... However, cephalosporins inhibit the SARS-CoV-2, and the results of the study and the effective cases imply that cephalosporins ... However, cephalosporins inhibit the SARS-CoV-2, and the results of the study and the effective cases imply that cephalosporins ... Cephalosporin Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026). Abstract The cephalosporin drugs ...
Since fourth-generation cephalosporins treat diseases other than food-bourne illnesses, the FDA is limited in its power to ... So approving the use of fourth-generation cephalosporins in cattle is a healthcare version of being penny-wise and pound- ... It makes sense that it is easier and cheaper to simply give those closely-packed cattle fourth-generation cephalosporins than ... When your kid has meningitis and 48 hours after starting a third-generation cephalosporin theres no improvement, that is not ...
Tag: cephalosporin. Posted inCosts U.S. drug shortages imperil cancer, maternity and other treatments. by Jeanne Pinder ...
... cephalosporins, clarithromycin antibiotic, k flex antibiotic, keflex antibiotic, macrolides, oral cephalosporins, quinolone ... Anti-Infectives : Antibiotic pills, Quinolone drugs, Cephalosporins, Macrolides. Antianginal, Antihypertensive, High Blood ...
Cephalosporins - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical Professional ... Contraindications to Cephalosporins Cephalosporins are contraindicated in patients with a history of major hypersensitivity to ... Cephalosporins are classified in generations (see table Some Clinical Uses of 3rd- and 4th-Generation Cephalosporins Some ... There are 5 generations of cephalosporins... read more , 2 Contraindications references Cephalosporins are bactericidal beta- ...
Studies on cephalosporin antibiotics. V. Synthesis, antibacterial activity and oral absorption of new 3-((Z)-2- ... I. Synthesis and antibacterial activity of 7.Beta.-[2-alkyl-and 2-hydroxy-2-(2-aminothiazol-4-yl)-acetamido]cephalosporins The ... I. Synthesis and antibacterial activity of 7 beta-[2-alkyl- and 2-hydroxy-2-(2-aminothiazol-4-yl)-acetamido]cephalosporins ... Synthesis and antibacterial activity of 7.Beta.-[2-amino-2-(2-aminothiazol-4-yl)acetamido]cephalosporins The Journal of ...
How are cephalosporins related to other β-lactam antibiotics?. Cephalosporins are a type of β-lactam antibiotic closely related ... How do cephalosporins work bacteria?. Cephalosporins are bactericidal drugs, meaning they kill bacteria directly. They do this ... Cephalosporins disrupt synthesis of the peptidoglycan layer of bacterial cell walls. How does cephalosporin bind to penicillin ... What is the mode of action of cephalosporins?. Cephalosporins are a type of β-lactam antibiotic closely related to the ...
... enrichment and sequencing of feces to enhance detection of antimicrobial resistance genes in third-generation cephalosporin ... enrichment and sequencing of feces to enhance detection of antimicrobial resistance genes in third-generation cephalosporin ...
The second-generation cephalosporins (cefamandole, cefaclor, cefotetan, cefoxitin, and cefuroxime) have an extended ... cephalosporins. * In antibiotic: Cephalosporins. The second-generation cephalosporins (cefamandole, cefaclor, cefotetan, ... In cephalosporin. , cefuroxime and cefamandole) and third-generation ones (such as ceftazidime) tend to be more effective ... Second-generation cephalosporins have proven effective against gonorrhea, Haemophilus influenzae, and the abscesses caused by ...
Remember more in less time and boost your test scores with Picmonic, the worlds best visual mnemonic learning resource and study aid for medical school, nursing school, and more! ...
Tag: cephalosporins. Beta lactams antibiotics (penicillins and cephalosporins) mechanism of action: videos and animations. ... Mechanism of action of the beta lactam antibiotics (penicillins and cephalosporins) The beta-lactam antibiotics can kill ...
Isolation of Penicillaminic Acid and D-α-Aminoadipic Acid from Cephalosporin N ...
Cephalosporins. Cephalosporins often treat gonorrhea, pelvic inflammatory disease, and sinusitis. They also treat urinary tract ... They are also a suitable option for people who are allergic to penicillin or cephalosporin. ... Appropriate use of cephalosporins. (2011). https://bpac.org.nz/bpj/2011/december/cephalosporins.aspx. ...
Copyrighted to Dr.M.G.R Educational and Research Institute, Maduravoyal, Chennai, Tamil Nadu ...
Since then, many cephalosporin drugs have been formulated, among them the third generation cephalosporin, which has a broader ... Cephalosporins Research Paper. 856 Words , 4 Pages. Cephalosporins are antimicrobial drugs that were first discovered in 1945 ...
":"Cephalosporins and Cephamycins - 1st Generation","data":{"category":"Medicine","linkRef":"Cephalosporins and Cephamycins - ... ":"Cephalosporins and Cephamycins - 2nd Generation","data":{"category":"Medicine","linkRef":"Cephalosporins and Cephamycins - ... ":"Cephalosporins and Cephamycins - 3rd Generation","data":{"category":"Medicine","linkRef":"Cephalosporins and Cephamycins - ... ":"Cephalosporins and Cephamycins - 4th Generation","data":{"category":"Medicine","linkRef":"Cephalosporins and Cephamycins - ...
Supplier of Cephalosporins Injection in Pune, Cephalosporins Injection Exporter Maharashtra, Cephalosporins Injection Supplier ... Pune, Cephalosporins Injection Manufacturing & Export company in India. ...
Everything you need to know to know about cephalosporins is in this study guide! ... This antibiotic study guide on cephalosporins is the perfect resource to help students prepare for the pharmacy technician ... Written by an experienced pharmacist, this study guide has everything you need to know about cephalosporins.. Ive even ... From learning about specific cephalosporins and their uses to how they are administered, there is so much information needed to ...
Johnson, A. P., Warner, M., Carter, M., & Livermore, D. M. (2002). In vitro activity of cephalosporin RWJ-54428 (MC-02479) ... Johnson, Alan P. ; Warner, Marina ; Carter, Michael ; Livermore, David M. / In vitro activity of cephalosporin RWJ-54428 (MC- ... Johnson, AP, Warner, M, Carter, M & Livermore, DM 2002, In vitro activity of cephalosporin RWJ-54428 (MC-02479) against ... RWJ-54428 (MC-02479) is a novel cephalosporin that binds to penicillin-binding protein (PBP) PBP 2 (PBP 2a) of methicillin- ...
Cephalosporins catalog,Buy quality Lincosamides products and find reliable Antiparasitic supplier & buyer on Drugdu.com ...
cephalosporin answers are found in the Tabers Medical Dictionary powered by Unbound Medicine. Available for iPhone, iPad, ... "Cephalosporin." Tabers Medical Dictionary, 24th ed., F.A. Davis Company, 2021. Nursing Central, nursing.unboundmedicine.com/ ... nursingcentral/view/Tabers-Dictionary/745765/all/cephalosporin. Cephalosporin. In: Venes DD, ed. Tabers Medical Dictionary. F. ... Cephalosporin [Internet]. In: Venes DD, editors. Tabers Medical Dictionary. F.A. Davis Company; 2021. [cited 2023 September 25 ...
  • Cephalosporins can be indicated for the prophylaxis and treatment of infections caused by bacteria susceptible to this particular form of antibiotic. (wikipedia.org)
  • Now we don't give cefepime to everyone with a bacterial infection for the same reason we don't give every person with a cough or cold an antibiotic: setting aside the fact that antibiotics can lead to life threatening infections , indiscriminant use of fourth-generation cephalosporins would increase the risk of bacteria evolving resistance to those antibiotics. (pandasthumb.org)
  • Cephalosporins are a type of β-lactam antibiotic closely related to the penicillins. (mexico-insights.com)
  • This antibiotic study guide on cephalosporins is the perfect resource to help students prepare for the pharmacy technician certification exam! (pharmprepdocs.com)
  • Start studying today with this Antibiotic Study Guide: Cephalosporins for the Pharmacy Technician Certification Exam (PTCB Exam, ExCPT, or PTCE)! (pharmprepdocs.com)
  • 16.Thornhill TS, Levison ME, Johnson WD, Kaye D. In vitro antimicrobial activity and human pharmacology of cephalexin, a new orally absorbed cephalosporin C antibiotic. (webmd.com)
  • Cephalosporin Antibiotic + B-lactamase inhibitor. (ibnhayyanpharma.com)
  • Ceftriaxone for injection, USP is a sterile, semisynthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular administration. (nih.gov)
  • Despite worsening renal function, failure to reduce the antibiotic dose further may have contributed to cephalosporin-induced encephalopathy (CIE). (e-jyms.org)
  • Cephalexin (cefalexin) is a cephalosporin antibiotic used to treat bacterial infections of the upper respiratory tract, the middle ear, the bones, the skin, and the reproductive and urinary systems. (nmn-powder.com)
  • Cefixime is a cephalosporin antibiotic used to treat infections caused by bacteria. (nmn-powder.com)
  • How do penicillins and cephalosporins work? (mexico-insights.com)
  • Mechanism of action of the beta lactam antibiotics (penicillins and cephalosporins) The beta-lactam antibiotics can kill susceptible bacteria. (pharmacologycorner.com)
  • The similarity in structure of the R1-side-chains of penicillins and cephalosporins determines the likelihood of cross-sensitivity between the drug classes - not the presence of the beta-lactam ring. (ebmconsult.com)
  • The structural similarities between penicillins and cephalosporins are the cause of the cross-reactivity between the two drug classes. (ebmconsult.com)
  • Penicillins and cephalosporins had no influence on overall survival among patients taking PD-1 blockers. (medscape.com)
  • CDC now recommends dual therapy for gonorrhea with a cephalosporin (ceftriaxone 250 mg) plus either azithromycin or doxycycline ( 4 ). (cdc.gov)
  • During that period, the percentage of isolates with elevated minimum inhibitory concentrations (MICs) to cephalosporins (≥0.25 µ g/mL for cefixime and ≥0.125 µ g/mL for ceftriaxone) increased from 0.2% in 2000 to 1.4% in 2010 for cefixime and from 0.1% in 2000 to 0.3% in 2010 for ceftriaxone. (cdc.gov)
  • MICs to cephalosporins (cefixime and ceftriaxone) among gonococcal isolates collected during 2000--2010 were analyzed. (cdc.gov)
  • Because few isolates exhibited decreased susceptibility and increases in MICs can precede the emergence of resistance, the percentage of isolates with elevated MICs (≥0.25 µ g/mL for cefixime and ≥0.125 µ g/mL for ceftriaxone) was assessed to determine if MICs to cephalosporins were increasing with time. (cdc.gov)
  • Cephalosporin (ceftriaxone) versus azithromycin. (ox.ac.uk)
  • Resistance to cephalosporin antibiotics can involve either reduced affinity of existing PBP components or the acquisition of a supplementary β-lactam-insensitive PBP. (wikipedia.org)
  • The potential emergence and spread of both oral and parenteral cephalosporin-resistance in N.gonorrhoeae (Ceph-R NG) needs to be monitored and appropriate action needs to be taken to avoid a major public health problem. (cdc.gov)
  • Third-generation cephalosporins frequently show good in vitro activity against these organisms, but, as explained above, a significant risk of developing full resistance during therapy exists. (medscape.com)
  • Resistance develops much less frequently with fourth-generation cephalosporins because they are relatively stable to AmpC beta-lactamase but not (so far) to the less frequently encountered ESBLs (see Medical Care). (medscape.com)
  • State and local public health departments should promote maintenance of laboratory capability to culture N. gonorrhoeae to allow testing of isolates for cephalosporin resistance. (cdc.gov)
  • Guelph, Ontario, Canada (R. crobial drug resistance is rapidly ris- sons resulting from third-generation Irwin);andOntarioVeterinaryCollege/Uni- ing, with resultant increased illness cephalosporin use in poultry, detailed versityofGuelph,Guelph(S.McEwen) and death. (cdc.gov)
  • Antimicrobial resistance generation cephalosporins ( 1 , 2 ). (cdc.gov)
  • 7 ). The United States Food meat, pigs and pork as sources of ExPEC from bloodstream infections caused by and Drug Administration recently pro- related virulence genes and resistance in Escherichia coli isolates from commu- third-generation cephalosporin-resis- hibited the off-label use of cephalo- nity-dwelling humans and UTI patients. (cdc.gov)
  • So approving the use of fourth-generation cephalosporins in cattle is a healthcare version of being penny-wise and pound-foolish: what good does it do to have discerning physicians who limit their use of fourth-generation cephalosporins when bugs can just evolve resistance to them when they're given to cattle indiscriminately? (pandasthumb.org)
  • It also makes sense that these analyses probably didn't put as much weight on the risk of evolving resistance to fourth-generation cephalosporins as would, say, people worried about dying from it. (pandasthumb.org)
  • They cited much evidence in support of their concerns, including the fact that the approval of fourth-generation cephalosporin use in Europe led to increased fourth-generation cephalosporin resistance in bacteria there. (pandasthumb.org)
  • Amino acid sequencing of some beta-lactamases has shown that substitution of only a few amino acids in the bla gene leads to high-level resistance against specific cephalosporins. (lu.se)
  • First-generation cephalosporins are active predominantly against Gram-positive bacteria, such as Staphylococcus and Streptococcus. (wikipedia.org)
  • Successive generations of cephalosporins have increased activity against Gram-negative bacteria, albeit often with reduced activity against Gram-positive organisms. (wikipedia.org)
  • A new cephalosporin with a highly reactive beta-lactam ring was found to give an immediate color change in the presence of beta-lactamases from many bacteria, including staphylococci, Bacillus species, Enterobacteriaceae, and Pseudomonas. (nih.gov)
  • The fifth-generation cephalosporins are found to be developed in the lab to specifically target resistant strains of bacteria. (bharatbook.com)
  • First, cefquinome is a fourth-generation cephalosporin, a class of antibiotics that have extremely broad spectra of activity against bacteria. (pandasthumb.org)
  • Of these, the cephalosporin (1a) with a hydroxyimino group in the C-7 side chain showed a potent antibacterial activity against Gram-negative bacteria and Gram-positive Staphylococcus aureus as well as good oral absorption in rats. (eurekamag.com)
  • Cephalosporins are bactericidal (kill bacteria) and work in a similar way to penicillins. (mexico-insights.com)
  • How do cephalosporins work bacteria? (mexico-insights.com)
  • Cephalosporins are bactericidal drugs, meaning they kill bacteria directly. (mexico-insights.com)
  • Third-generation cephalosporins are more effective against Gram-negative bacteria compared to both the first and second generations. (mexico-insights.com)
  • They're also more active against bacteria that may be resistant to previous generations of cephalosporins. (mexico-insights.com)
  • A Cephalosporin Drugs is a group of semi-synthetic, wide-spectrum antibiotics mainly used to treat infections of bacteria. (powershow.com)
  • Ceftaroline has also been described as the fifth-generation cephalosporin but does not have the antipseudomonal or VRE coverage of ceftobiprole. (bharatbook.com)
  • The antimicrobials most commonly indicated in Enterobacter infections include carbapenems, fourth-generation cephalosporins, aminoglycosides, fluoroquinolones, and TMP-SMZ. (medscape.com)
  • From my experience as a physician, I can tell you that when someone is extremely sick in the ICU, fourth-generation cephalosporins like cefepime are often the first drugs we reach for, especially if the patient has a penicillin allergy. (pandasthumb.org)
  • It makes sense that it is easier and cheaper to simply give those closely-packed cattle fourth-generation cephalosporins than it is to take steps to prevent disease virulence in the first place. (pandasthumb.org)
  • Fourth-Generation Cephalosporins. (powershow.com)
  • citation needed] The commonly quoted figure of 10% of patients with allergic hypersensitivity to penicillins and/or carbapenems also having cross-reactivity with cephalosporins originated from a 1975 study looking at the original cephalosporins, and subsequent "safety first" policy meant this was widely quoted and assumed to apply to all members of the group. (wikipedia.org)
  • Penicillins, cephalosporins, carbapenems and monobactams all inhibit peptidoglycan cross-linking through interaction of the common β-lactam ring with the transpeptidase enzymes. (pharmacy180.com)
  • Cephalosporin use tal admissions would be counted as a Aarestrup);WorldHealthOrganizationCol- result of cephalosporin and other anti- in Poultry, Europe laborating Centre for Antimicrobial Resis- microbial drug use in poultry. (cdc.gov)
  • Selection criteria: We included randomized controlled trials (RCTs) in adults and children with enteric fever that compared a cephalosporin to another antimicrobial, a different cephalosporin, or a different treatment duration of the intervention cephalosporin. (ox.ac.uk)
  • Salmonella Heidelberg resistant to ceftiofur (a third-generation cephalosporin antimicrobial agent ) in broiler chicken products pose a risk to public health in Canada . (bvsalud.org)
  • This medication belongs to a class of drugs known as cephalosporin antibiotics. (mexico-insights.com)
  • Degradation, structure and some derivatives of cephalosporin N. (wikidata.org)
  • Third generation cephalosporins remain the sole class of antibiotics available which can be used effectively against N.gonorrhoeae . (cdc.gov)
  • Ceftolozane is in a class of antibiotics called cephalosporins. (medlineplus.gov)
  • Cephalosporin (cefixime) versus fluoroquinolones. (ox.ac.uk)
  • Cephalosporins are bactericidal and, like other β-lactam antibiotics, disrupt the synthesis of the peptidoglycan layer forming the bacterial cell wall. (wikipedia.org)
  • From learning about specific cephalosporins and their uses to how they are administered, there is so much information needed to know before taking the exam. (pharmprepdocs.com)
  • A Cochrane Review of the use of fluoroquinolones and azithromycin in the treatment of enteric fever has previously been undertaken, but the use of cephalosporins has not been systematically investigated and the optimal choice of drug and duration of treatment are uncertain. (ox.ac.uk)
  • The second-generation cephalosporins (cefamandole, cefaclor, cefotetan, cefoxitin, and cefuroxime) have an extended antibacterial spectrum that includes greater activity against additional species of gram-negative rods. (britannica.com)
  • Cefepime is a fourth-generation cephalosporin. (medscape.com)
  • Cephalosporins possess a mechanism of action identical to penicillins: inhibition of bacterial cell wall peptidoglycan synthesis by inhibition of penicillin-sensitive enzymes (transpeptidases, carboxypeptidases) that are responsible for the final three-dimensional structure of the rigid bacterial cell wall. (mexico-insights.com)
  • Cephalosporins disrupt synthesis of the peptidoglycan layer of bacterial cell walls. (mexico-insights.com)
  • cefuroxime and cefamandole) and third-generation ones (such as ceftazidime) tend to be more effective against gram-negative bacterial species that are resistant to the first-generation cephalosporins. (britannica.com)
  • Nevertheless, the side effects of Cephalosporin Drugs and the development of drug-resistant bacterial strains restrict the growth of the market. (powershow.com)
  • The cephalosporin drugs market was valued at approximately USD 14,010 million in 2020, and it is expected to reach USD 16,490 million by 2026, registering a CAGR of 2.75% during the forecast period, 2021-2026. (bharatbook.com)
  • 2021. https://nursing.unboundmedicine.com/nursingcentral/view/Tabers-Dictionary/745765/all/cephalosporin. (unboundmedicine.com)
  • How does cephalosporin bind to penicillin binding protein 3? (mexico-insights.com)
  • RWJ-54428 (MC-02479) is a novel cephalosporin that binds to penicillin-binding protein (PBP) PBP 2' (PBP 2a) of methicillin-resistant staphylococci. (uea.ac.uk)
  • However, cephalosporins inhibit the SARS-CoV-2, and the results of the study and the effective cases imply that cephalosporins may work against the SARS-CoV-2 virus. (bharatbook.com)
  • Cefotetan is a second-generation cephalosporin that is used as single-drug therapy for broad gram-negative and anaerobic coverage. (medscape.com)
  • Empirical treatment with neuraminidase inhibitors and the combination of cephalosporins and macrolides or quinolones are suggested to be an effective treatment for COVID-19. (bharatbook.com)
  • Also, the cephalosporins in combinations with macrolides and quinolones may be potentially effective against COVID-19 (SARS-CoV-2). (bharatbook.com)
  • First-generation and second-generation cephalosporins are inactive against Enterobacter infections. (medscape.com)
  • Third-generation cephalosporins are not indicated for the treatment of severe Enterobacter infections, perhaps with the notable exception of uncomplicated infections. (medscape.com)
  • Although cephalosporins remain an effective treatment for gonococcal infections, health-care providers should be vigilant for treatment failure and are requested to report its occurrence to state and local health departments. (cdc.gov)
  • This drug is also a second-generation cephalosporin that is indicated as single agent for the management of infections caused by susceptible gram-positive cocci and gram-negative rods. (medscape.com)
  • The emergence of multidrug resistant gonococcal strains which are resistant to both oral and injectable cephalosporin drugs could have a catastrophic effect on gonorrhea control activities. (cdc.gov)
  • The market growth is also attributed to the increase in consumption of cephalosporin, easier availability, and a rise in demand for over-the-counter drugs. (bharatbook.com)
  • The increasing number of clinical trials for R&D of cephalosporin drugs is also expected to propel the growth of the cephalosporin drugs market over the forecast period. (bharatbook.com)
  • Hence, all these factors may help the cephalosporin drugs market to witness high growth over the forecast period. (bharatbook.com)
  • Cephalosporins are grouped into five generations based on when the drugs were developed. (mexico-insights.com)
  • Cephalosporin Drugs Market - Global cephalosporin drugs market is expected to witness significant growth during the forecast period on account of the rapid introduction of new treatments for various infectious diseases and increasing healthcare spending. (powershow.com)
  • Cephalosporin Drugs Market Size- KBV Research - The Global Cephalosporin Drugs Market size is expected to reach $14.1 billion by 2025, rising at a market growth of 3.34% CAGR during the forecast period. (powershow.com)
  • Global Cephalosporin Drugs Market: Trend Analysis and Forecast to 2022 - The report on Cephalosporin Drugs Market by Infinium Global Research analyzes over the period of 2016 to 2022. (powershow.com)
  • This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Cephalosporin Drugs Market. (powershow.com)
  • It will help a lot of decision makers to develop strategies and find new opportunities in the Global Cephalosporin Drugs Market. (powershow.com)
  • According to the report the Global Cephalosporin Drugs Market is projected to grow at a CAGR of 13.9% in terms of value over the period of 2017-2023. (powershow.com)
  • Global Cephalosporin Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. (bharatbook.com)
  • The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Cephalosporin involved the extensive usage of both primary and secondary data sources. (bharatbook.com)
  • Many of the cephalosporins, e.g. cephalexin, cefotaxime and ceftazidime, bind to PBP3 resulting in the formation of elongated, filamentous cells. (pharmacy180.com)
  • The fifth-generation cephalosporins include ceftobiprole, ceftaroline, and ceftolozane. (bharatbook.com)
  • This report summarizes trends in cephalosporin susceptibility among N. gonorrhoeae isolates in the United States during 2000--2010 using data from the Gonococcal Isolate Surveillance Project (GISP). (cdc.gov)
  • This, however, should be viewed in the light of recent epidemiological work suggesting, for many second-generation (or later) cephalosporins, the cross-reactivity rate with penicillin is much lower, having no significantly increased risk of reactivity over the first generation based on the studies examined. (wikipedia.org)
  • The newer generation cephalosporin antibiotics have different R1-side chains making the cross-reactivity low and likelihood of allergic reaction even lower compared to some of the first generation agents and penicillin. (ebmconsult.com)
  • A farm-to-fork quantitative risk assessment model for Salmonella Heidelberg resistant to third-generation cephalosporins in broiler chickens in Canada. (bvsalud.org)
  • Third-generation cephalosporins have less coverage against most gram-positive organisms but have increase coverage against Enterobacteriaceae, Neisseria spp. (mexico-insights.com)
  • Common adverse drug reactions (ADRs) (≥ 1% of patients) associated with the cephalosporin therapy include: diarrhea, nausea, rash, electrolyte disturbances, and pain and inflammation at injection site. (wikipedia.org)
  • 4.Brown GR. Cephalosporin-probenecid drug interactions. (webmd.com)
  • 5.Welling PG, Dean S, Selen A, Kendall MJ, Wise R. Probenecid: an unexplained effect on cephalosporin pharmacology. (webmd.com)
  • Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function. (webmd.com)
  • Therefore, there are in vitro and in vivo studies going on to evaluate the potential of generations of cephalosporin for COVID-19. (bharatbook.com)
  • There are 5 generations of cephalosporins. (msdmanuals.com)
  • Thus, consumption of alcohol after taking Cephalosporin orally or intravenously is contraindicated, and in severe cases can lead to death. (wikipedia.org)
  • Recent papers have shown that a major feature in determining frequency of immunological reactions is the similarity of the side chains (e.g., first generation cephalosporins are similar to penicillins), and this is the reason the β-lactams are associated with different frequencies of serious reactions (e.g., anaphylaxis). (wikipedia.org)
  • What do second generation cephalosporins treat? (mexico-insights.com)
  • Second-generation cephalosporins have coverage against Haemophilus influenza (H. influenza), Moraxella catarrhalis, and Bacteroides spp. (mexico-insights.com)
  • Second-generation cephalosporins have proven effective against gonorrhea, Haemophilus influenzae, and the abscesses caused by Bacteroides fragilis . (britannica.com)
  • Many first- and second-generation cephalosporins have similar side-chains to penicillin antibiotics, thus increasing the chance of cross-sensitivity. (ebmconsult.com)
  • Cephalosporins often treat gonorrhea, pelvic inflammatory disease , and sinusitis. (healthline.com)
  • Often, doctors prescribe cephalosporins to people who are allergic to penicillin. (healthline.com)
  • They are also a suitable option for people who are allergic to penicillin or cephalosporin. (healthline.com)
  • Historically, 10% of patients with a previous penicillin allergy were also allergic to cephalosporins. (ebmconsult.com)
  • A series of new 3-[(Z)-2-methoxycarbonylvinylthio]-7 beta-[(2- aminothiazol-4-yl)acetamido]-cephalosporins (1) having various oxyimino groups (Z-form) at the alpha position of the C-7 side chain was synthesized and evaluated for antibacterial activity and oral absorption in rats. (eurekamag.com)
  • The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cephalosporin market in 2020. (bharatbook.com)
  • The main comparisons are between antimicrobials in most common clinical use, namely cephalosporins compared to a fluoroquinolone and cephalosporins compared to azithromycin. (ox.ac.uk)
  • The proposed model was tested on the experimental data from the literature and could adequately describe the morphological differentiation of cells, the sequential utilization of carbon sources and the production of cephalosporin C. It could be a useful tool to optimize the production of cephalosporin C by Cephalosporium acremonium in batch, fed-batch or continuous operations. (korea.ac.kr)
  • Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Cephalosporin Market along with their impact on demand during the forecast period. (bharatbook.com)
  • A cybernetic mathematical model has been developed to describe the production of cephalosporin C. In developing the model, diauxic behavior of substrate consumption, morphological differentiation of cells, and catabolite repression of cephalosporin C production by the preferred substrate, glucose, were considered. (korea.ac.kr)
  • The fifth-generation cephalosporins are not active against Pseudomonas species. (bharatbook.com)
  • What is the difference between 1st 2nd and 3rd generation cephalosporins? (mexico-insights.com)
  • third-Generation Cephalosporins. (powershow.com)
  • Note that newer generation cephalosporin antibiotics have different R1-side chains compared to the first generation agents and penicillin. (ebmconsult.com)